{"meta":{"query_hash":"79cc2530f486","filters":{"venue":"Expert Review of Hematology"},"cohort_total":73,"direct_labels_cover":0,"predictions_cover":73,"exported":73,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/79cc2530f486","api":"https://metacan.xera.ac/api/v1/cohort?venue=Expert+Review+of+Hematology"},"results":[{"id":"W1856197384","doi":"10.1586/17474086.2015.1071186","title":"Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countries","year":2015,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Intensive care medicine; Lymphoblastic Leukemia; Disease; Poverty; Infectious disease (medical specialty); Economic shortage; Pediatrics; Immunology; Leukemia; Internal medicine; Economic growth","score_opus":0.02188836468672579,"score_gpt":0.3468926346957215,"score_spread":0.32500427000899573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1856197384","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021471859,0.9980584,0.000062693856,0.00052023464,0.00014244033,0.0000066229813,0.00003577763,0.0000054838256,0.0009535052],"genre_scores_gemma":[0.001435533,0.99776745,0.00014438132,0.00026403266,0.0001286255,0.000006590893,0.00004038686,0.0000010323912,0.00021192567],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99963796,0.0000961599,0.00007493813,0.00004319279,0.00012050955,0.000027236365],"domain_scores_gemma":[0.9995092,0.00025011844,0.00010754545,0.00000841628,0.00009634127,0.000028241799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005112967,0.00047322598,0.0008326795,0.0014458671,0.00026876814,0.00085836067,0.00050584384,0.0007352701,0.0032438214],"category_scores_gemma":[0.0016452012,0.00013227385,0.0005956281,0.0013272814,0.00023320009,0.00061333244,0.00049227313,0.00097171817,0.0006827413],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058817503,0.000039341307,0.0013083303,0.030728346,0.00020419864,0.0003405731,0.00015695322,0.00020860771,0.00046275638,0.0017914914,0.035340108,0.92936045],"study_design_scores_gemma":[0.000029286086,0.0001266351,0.005544344,0.04211809,0.00058766437,0.0055029085,0.00029038914,0.0001184617,0.0003876113,0.0019587756,0.9433061,0.000029735871],"about_ca_topic_score_codex":0.0021645175,"about_ca_topic_score_gemma":0.004122561,"teacher_disagreement_score":0.0032438214,"about_ca_system_score_codex":0.00045698803,"about_ca_system_score_gemma":0.0015662824,"threshold_uncertainty_score":0.010851681},"labels":[],"label_agreement":null},{"id":"W1948056367","doi":"10.1586/17474086.2015.1049594","title":"Supportive medical care for children with acute lymphoblastic leukemia in low- and middle-income countries","year":2015,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Medicine; Intensive care medicine; Lymphoblastic Leukemia; Anemia; Palliative care; Tumor lysis syndrome; Supportive psychotherapy; Health care; Pediatrics; Leukemia; Internal medicine; Nursing; Chemotherapy","score_opus":0.020152062845790405,"score_gpt":0.3622676101564847,"score_spread":0.34211554731069427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1948056367","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010244675,0.99832517,0.000057861052,0.00058748166,0.00014099141,0.000005242465,0.000015709773,0.000004267149,0.0007608271],"genre_scores_gemma":[0.0008725738,0.9983442,0.00017004687,0.00028570034,0.00014579682,0.0000066758253,0.000021600546,7.3711755e-7,0.00015269368],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996612,0.000111953515,0.00006755882,0.000040094255,0.00009627077,0.000022843255],"domain_scores_gemma":[0.99932027,0.0003839829,0.00012820588,0.0000134425445,0.000121087825,0.000033095264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072923955,0.000523358,0.000786681,0.0016441881,0.00030194598,0.0008688643,0.0007229239,0.0009607006,0.0032580502],"category_scores_gemma":[0.0018097078,0.0001402273,0.0005580495,0.0014468122,0.0003376276,0.0007642909,0.0006877718,0.0011119456,0.00093834],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003581392,0.000040172778,0.00041014783,0.036165733,0.00015316461,0.00020082138,0.00013777068,0.00016590572,0.00039663064,0.0020957005,0.034402225,0.9257959],"study_design_scores_gemma":[0.00003217669,0.00009463706,0.0026614873,0.047046058,0.0004245264,0.002682895,0.00028893971,0.00009095716,0.0002655605,0.0021945892,0.94419277,0.000025331203],"about_ca_topic_score_codex":0.0016627674,"about_ca_topic_score_gemma":0.0033626663,"teacher_disagreement_score":0.0032580502,"about_ca_system_score_codex":0.00059880916,"about_ca_system_score_gemma":0.0015982677,"threshold_uncertainty_score":0.010899246},"labels":[],"label_agreement":null},{"id":"W1969524425","doi":"10.1586/17474086.2014.873699","title":"The emerging role of carfilzomib combination therapy in the management of multiple myeloma","year":2014,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Carfilzomib; Medicine; Bortezomib; Proteasome inhibitor; Multiple myeloma; Pharmacology; Oncology; Refractory (planetary science); Clinical trial; Internal medicine; Biology","score_opus":0.038215541105202006,"score_gpt":0.40029644227368966,"score_spread":0.3620809011684877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969524425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000086579064,0.9991303,0.000058662215,0.0002242018,0.00008907268,0.00000297965,0.000009904999,0.0000034370737,0.0003949389],"genre_scores_gemma":[0.00059548457,0.9987129,0.00013159681,0.00019492069,0.0001303392,0.0000044535614,0.000019877227,9.573278e-7,0.00020954158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977356,0.000052660293,0.000034913377,0.000036551795,0.0000811686,0.000021197957],"domain_scores_gemma":[0.99959666,0.00019208246,0.00006740607,0.000008654034,0.00010256303,0.000032552944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007810471,0.0006390403,0.0015098808,0.0019493159,0.00024283661,0.0009589805,0.00096052536,0.0010473885,0.004175975],"category_scores_gemma":[0.00076354033,0.0002021865,0.00068974396,0.0019095477,0.0003981833,0.001106525,0.0006590296,0.0019203759,0.0014971601],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008212084,0.00006115613,0.000134069,0.015018461,0.00013673231,0.00016805327,0.00004146069,0.00022019136,0.0009190123,0.001626233,0.019049075,0.96254337],"study_design_scores_gemma":[0.00006487894,0.00019786462,0.0010400281,0.0060008517,0.00033661115,0.0019538943,0.00007311028,0.00012012191,0.00041694878,0.001818961,0.9879529,0.000023811432],"about_ca_topic_score_codex":0.0010007928,"about_ca_topic_score_gemma":0.002361645,"teacher_disagreement_score":0.004175975,"about_ca_system_score_codex":0.000522909,"about_ca_system_score_gemma":0.000937759,"threshold_uncertainty_score":0.013969958},"labels":[],"label_agreement":null},{"id":"W1970311996","doi":"10.1586/17474086.1.1.75","title":"Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis","year":2008,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Heparin; Heparin-induced thrombocytopenia; Platelet; Thrombosis; Platelet factor 4; Platelet activation; Discovery and development of direct thrombin inhibitors; Internal medicine; Low molecular weight heparin; Thrombin; Surgery","score_opus":0.04446902066069388,"score_gpt":0.36745661531091617,"score_spread":0.3229875946502223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970311996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00055947865,0.99787724,0.00011643401,0.00032151223,0.00013700675,0.00000459072,0.000018473098,0.000005392466,0.0009598426],"genre_scores_gemma":[0.004776918,0.99394506,0.00022941922,0.00023682618,0.00029615388,0.0000122745105,0.00005106328,8.811533e-7,0.00045143734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981743,0.00004678431,0.000027812472,0.000023606613,0.00007150893,0.000012967866],"domain_scores_gemma":[0.9997763,0.00009248005,0.000056913883,0.000003736865,0.000051661056,0.000018901757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028508817,0.0005153843,0.0014483401,0.0007846899,0.00013850306,0.0004738726,0.0005291886,0.00081587536,0.0030184586],"category_scores_gemma":[0.0007942197,0.000106174535,0.00032831685,0.0012581139,0.00011244803,0.0003477913,0.00020841797,0.0006293275,0.001159677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015407687,0.0000788387,0.0034919379,0.009259441,0.00023656133,0.0009891135,0.00004789398,0.00018108904,0.0006634501,0.0006967623,0.027896846,0.956304],"study_design_scores_gemma":[0.00028847932,0.00068417884,0.041027788,0.020025197,0.0017777077,0.03491356,0.0003105698,0.0006061009,0.0010139289,0.0030835196,0.89620054,0.00006850782],"about_ca_topic_score_codex":0.0006845956,"about_ca_topic_score_gemma":0.00074614916,"teacher_disagreement_score":0.0030184586,"about_ca_system_score_codex":0.00020714804,"about_ca_system_score_gemma":0.00061791844,"threshold_uncertainty_score":0.010097802},"labels":[],"label_agreement":null},{"id":"W1975247464","doi":"10.1586/ehm.10.54","title":"Fondaparinux: does it cause HIT? can it treat HIT?","year":2010,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Fondaparinux; Medicine; Heparin-induced thrombocytopenia; Heparin; Immunogenicity; Anticoagulant; Antibody; Immunology; Internal medicine; Thrombosis; Venous thromboembolism","score_opus":0.07088286175210595,"score_gpt":0.4156462738865622,"score_spread":0.34476341213445627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975247464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010167075,0.99795985,0.00004804831,0.0010582056,0.0002513962,0.0000021475862,0.000007869243,0.00000371537,0.00056710985],"genre_scores_gemma":[0.0012123982,0.9963026,0.000120226534,0.0010772253,0.00056715595,0.0000056320964,0.000017098564,0.0000023386385,0.00069535314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997037,0.00006751197,0.00004552337,0.00004539695,0.00011714198,0.000020730493],"domain_scores_gemma":[0.99952877,0.0002350388,0.00008801028,0.000013834708,0.00009880014,0.000035527235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080301735,0.0006623423,0.0025839268,0.0013097803,0.00028431564,0.0010080165,0.00081149046,0.0019658857,0.0038669545],"category_scores_gemma":[0.0012929215,0.00027828926,0.0006367781,0.0017427033,0.0006190632,0.0014736019,0.0003479019,0.0020369687,0.0024204762],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014070942,0.00006505255,0.00026004793,0.010112097,0.00018105238,0.0003245792,0.00004173233,0.00011354263,0.0005369006,0.0018410124,0.03920665,0.9471765],"study_design_scores_gemma":[0.00022622163,0.00018989008,0.0020043436,0.008132404,0.0004539289,0.00508219,0.00011398268,0.00012857997,0.00055847474,0.0032784855,0.97979635,0.000035077363],"about_ca_topic_score_codex":0.0013727621,"about_ca_topic_score_gemma":0.0023764714,"teacher_disagreement_score":0.0038669545,"about_ca_system_score_codex":0.00051488174,"about_ca_system_score_gemma":0.0007850777,"threshold_uncertainty_score":0.0129362345},"labels":[],"label_agreement":null},{"id":"W1979172522","doi":"10.1586/17474086.2014.873285","title":"Multiple myeloma: genome sequencing, drug development and the future outlook","year":2014,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; Leukemia and Lymphoma Society; Multiple Myeloma Research Foundation","keywords":"Medicine; Family medicine; Multiple myeloma; Library science; Oncology; Internal medicine; Gerontology","score_opus":0.006525124098754515,"score_gpt":0.2456722739160622,"score_spread":0.23914714981730767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979172522","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007018431,0.78838706,0.006831486,0.18464772,0.0031932837,0.00005015528,0.0010683964,0.0003431007,0.008460316],"genre_scores_gemma":[0.039154436,0.90811795,0.013317233,0.028548665,0.0039775777,0.00009956597,0.0017886964,0.00010327652,0.004892576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99931586,0.00024928068,0.000050802097,0.00009262894,0.00018651059,0.00010498257],"domain_scores_gemma":[0.99620557,0.0011823447,0.00031699278,0.00017914212,0.0012865737,0.0008292901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006101062,0.000763484,0.0013665394,0.0013131553,0.00032885597,0.0026931623,0.00087037944,0.0030410097,0.0051835817],"category_scores_gemma":[0.0048219906,0.0003392659,0.000719664,0.0017060896,0.0012322647,0.0030208877,0.00080613245,0.0032841566,0.0022395977],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009927774,0.00017033861,0.002455199,0.0020547728,0.00019612811,0.0004506988,0.00010826493,0.0027229898,0.0076706973,0.024733951,0.16394304,0.7945012],"study_design_scores_gemma":[0.00022455891,0.0008000121,0.004925105,0.002170085,0.00024807482,0.0014716256,0.0002697556,0.002831133,0.0030859131,0.04541796,0.938485,0.000070739356],"about_ca_topic_score_codex":0.0024301775,"about_ca_topic_score_gemma":0.0031092018,"teacher_disagreement_score":0.006101062,"about_ca_system_score_codex":0.0025222637,"about_ca_system_score_gemma":0.00492598,"threshold_uncertainty_score":0.032265842},"labels":[],"label_agreement":null},{"id":"W1997682944","doi":"10.1586/ehm.12.10","title":"Bleeding risk assessment during oral anticoagulant therapy initiation","year":2012,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Oral anticoagulant; Intensive care medicine; Venous thromboembolism; Anticoagulant therapy; Risk assessment; Anticoagulant; Warfarin; Surgery; Internal medicine; Thrombosis; Atrial fibrillation","score_opus":0.05970464769289128,"score_gpt":0.42719482262660036,"score_spread":0.36749017493370906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997682944","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018412621,0.05892657,0.00069052074,0.07125177,0.8670593,0.000047334717,0.00018389316,0.00009660188,0.0015598784],"genre_scores_gemma":[0.0015333347,0.03054731,0.0006116061,0.026799748,0.93747336,0.000050594736,0.0000767318,0.000029285256,0.0028781039],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99355716,0.0017459558,0.0016326406,0.0005648689,0.0022749112,0.00022453189],"domain_scores_gemma":[0.9582669,0.02456892,0.0024292914,0.0006491004,0.012618025,0.0014677877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010648335,0.0034961528,0.006013971,0.0035102055,0.0014526934,0.0054759653,0.0024865817,0.01419587,0.0033069784],"category_scores_gemma":[0.048513036,0.0014678297,0.0029923422,0.0016526452,0.0017596269,0.0027655396,0.0010464176,0.022668889,0.0029750452],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016689609,0.000033229335,0.00028336345,0.00107941,0.00026280715,0.00019443217,0.000030208892,0.00008623531,0.000048594367,0.0003716957,0.969606,0.027837176],"study_design_scores_gemma":[0.0011992436,0.0002126438,0.003616015,0.010314565,0.0023402434,0.0018339033,0.00012702263,0.0016876439,0.00044771665,0.0031444507,0.97493696,0.00013958054],"about_ca_topic_score_codex":0.0025791053,"about_ca_topic_score_gemma":0.006175485,"teacher_disagreement_score":0.01419587,"about_ca_system_score_codex":0.002573103,"about_ca_system_score_gemma":0.0036491705,"threshold_uncertainty_score":0.05631447},"labels":[],"label_agreement":null},{"id":"W2019408825","doi":"10.1586/ehm.11.5","title":"Quebec platelet disorder","year":2011,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Pathogenesis; Medicine; Mutation; Gene; Platelet; Cancer research; Fibrinolysis; Activator (genetics); Plasminogen activator; Platelet disorder; Genetics; Immunology; Biology; Internal medicine","score_opus":0.023699298015248994,"score_gpt":0.3143188883507248,"score_spread":0.2906195903354758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019408825","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06582955,0.26276663,0.0059623052,0.04337621,0.0032441048,0.0006567471,0.00920244,0.0006255929,0.6083365],"genre_scores_gemma":[0.635131,0.1024607,0.0062498213,0.024418736,0.0009898462,0.0003359991,0.006305989,0.00010944624,0.22399841],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99956423,0.000057716745,0.000022918804,0.00007076177,0.00016650339,0.00011789958],"domain_scores_gemma":[0.99937695,0.000085941094,0.00007177217,0.00002395587,0.00032315115,0.00011837994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038901338,0.0005999314,0.000439766,0.0009722905,0.002149745,0.0013613448,0.0007017687,0.0012628026,0.032139137],"category_scores_gemma":[0.0017116129,0.00012286025,0.0003257543,0.0014834377,0.0006363904,0.00041132275,0.0004385189,0.0010155641,0.0023827427],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004621674,0.00013659937,0.02808788,0.0012093915,0.00022036508,0.034980245,0.0008118224,0.0005753292,0.005377722,0.04625076,0.44988984,0.431998],"study_design_scores_gemma":[0.00018746601,0.00012004554,0.03386843,0.0007548665,0.00014468607,0.045904692,0.00049554196,0.00072736247,0.0013046091,0.0033516749,0.91307914,0.000061398045],"about_ca_topic_score_codex":0.72555184,"about_ca_topic_score_gemma":0.78674567,"teacher_disagreement_score":0.27444816,"about_ca_system_score_codex":0.01223891,"about_ca_system_score_gemma":0.007881631,"threshold_uncertainty_score":0.55212885},"labels":[],"label_agreement":null},{"id":"W2054095502","doi":"10.1586/17474086.2014.965140","title":"Anti-infective prophylaxis in pediatric patients with acute myeloid leukemia","year":2014,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Myeloid leukemia; Antibiotic prophylaxis; Antibiotics; Bacteremia; Intensive care medicine; Myeloid; Internal medicine; Immunology; Microbiology","score_opus":0.012770121401791897,"score_gpt":0.3329687169134856,"score_spread":0.3201985955116937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054095502","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007969657,0.99954766,0.00001767548,0.000082980856,0.00004639443,0.0000021004118,0.000005815623,0.0000011978108,0.00021649605],"genre_scores_gemma":[0.0008035801,0.9988669,0.00005842496,0.0000983316,0.00006381758,0.000003209661,0.000012385294,3.4059903e-7,0.00009300459],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997478,0.00006292198,0.00005663283,0.000032493474,0.00008413719,0.000015974496],"domain_scores_gemma":[0.9995925,0.00022490698,0.00009231274,0.0000058992396,0.00006657196,0.000017790988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004454343,0.0005620996,0.0010813376,0.0014796484,0.0001674717,0.0005927249,0.0006869949,0.0007772822,0.0025019418],"category_scores_gemma":[0.0011159622,0.00016300243,0.0005903586,0.0014296337,0.00019703091,0.00057535566,0.00037126773,0.0009066184,0.0005344745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007472592,0.00005656996,0.00038994988,0.04425599,0.00024442616,0.00023296342,0.000058514324,0.00016056864,0.0005072657,0.0009050546,0.017853327,0.93526065],"study_design_scores_gemma":[0.000105655854,0.0002585439,0.005073412,0.058477648,0.0013367258,0.0063079624,0.00017111163,0.00018044868,0.00061965175,0.0015450823,0.9258855,0.000038281054],"about_ca_topic_score_codex":0.0010090994,"about_ca_topic_score_gemma":0.0022925134,"teacher_disagreement_score":0.0025019418,"about_ca_system_score_codex":0.0003407021,"about_ca_system_score_gemma":0.0008102943,"threshold_uncertainty_score":0.008369803},"labels":[],"label_agreement":null},{"id":"W2054623522","doi":"10.1586/ehm.11.59","title":"Treatment of warfarin-associated coagulopathy with vitamin K","year":2011,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Warfarin; Medicine; Prothrombin complex concentrate; Coagulopathy; Clotting factor; Fresh frozen plasma; Oral anticoagulant; Anticoagulant; Vitamin; Prothrombin time; Anesthesia; Surgery; Internal medicine; Atrial fibrillation; Platelet","score_opus":0.1111017497580846,"score_gpt":0.40938071076811033,"score_spread":0.2982789610100257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054623522","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002507703,0.99832255,0.0001495179,0.00021554879,0.00010658428,0.000007724961,0.000013400236,0.000008723926,0.0009252285],"genre_scores_gemma":[0.0021075916,0.996896,0.00022615654,0.00017386934,0.00014796415,0.000009154205,0.000038560935,0.0000017456782,0.00039885225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972266,0.00005182996,0.0000531804,0.000039090075,0.000112311056,0.000020963398],"domain_scores_gemma":[0.9997701,0.000094325595,0.0000645992,0.000008776291,0.00004644416,0.000015669008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041615515,0.0006556017,0.0016978395,0.0020401934,0.00021606291,0.00060134765,0.000879189,0.0008351413,0.0025477912],"category_scores_gemma":[0.0008010177,0.00016325785,0.0006937674,0.0015478486,0.00026841988,0.00056559796,0.00046431288,0.0011078243,0.001722682],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009952706,0.000105115105,0.00032578965,0.017608045,0.00026772954,0.0005107652,0.00003169221,0.00016551442,0.0011135383,0.000696074,0.02127991,0.95779634],"study_design_scores_gemma":[0.00022866654,0.00034658457,0.0038132214,0.011581452,0.0007084371,0.013096142,0.00008930618,0.00024775046,0.0022097833,0.0019692092,0.9656726,0.000036801895],"about_ca_topic_score_codex":0.0009875308,"about_ca_topic_score_gemma":0.0013647791,"teacher_disagreement_score":0.0025477912,"about_ca_system_score_codex":0.00038781093,"about_ca_system_score_gemma":0.00064947596,"threshold_uncertainty_score":0.008523226},"labels":[],"label_agreement":null},{"id":"W2076008996","doi":"10.1586/ehm.12.8","title":"Therapeutic potential of mitochondrial translation inhibition for treatment of acute myeloid leukemia","year":2012,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Myeloid leukemia; Translation (biology); Cancer research; Myeloid; Leukemia; Oncology; Pharmacology; Internal medicine; Gene; Messenger RNA; Genetics","score_opus":0.015857131548587863,"score_gpt":0.3113172917942411,"score_spread":0.29546016024565325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076008996","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019281056,0.120188214,0.00051361014,0.03490348,0.8412755,0.000036100388,0.00007420987,0.00008632419,0.0027297605],"genre_scores_gemma":[0.0016545485,0.08437139,0.00045531054,0.023353275,0.87810177,0.000037802856,0.00006889184,0.000032906584,0.011924109],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901915,0.00020518703,0.00015344204,0.00012409891,0.00041734506,0.000080883576],"domain_scores_gemma":[0.997517,0.0010327745,0.00021334592,0.000050326285,0.00085651624,0.00033006782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026824754,0.0019873118,0.0021618076,0.0013373463,0.0008625404,0.0023449566,0.0019651682,0.0061147255,0.0048247646],"category_scores_gemma":[0.004088145,0.00043956775,0.0014371544,0.0006162516,0.0010623924,0.0017912111,0.00077243696,0.010234131,0.0030321921],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015173623,0.000027272712,0.000022713435,0.00090380426,0.0000491718,0.00028555826,0.000013434273,0.00005333259,0.0004702208,0.00075759704,0.9578341,0.039430875],"study_design_scores_gemma":[0.00014809657,0.00011036009,0.00022380645,0.0004139133,0.00010870973,0.000768253,0.000021300364,0.00016178747,0.00052069,0.0008273906,0.9966754,0.000020351852],"about_ca_topic_score_codex":0.0005240613,"about_ca_topic_score_gemma":0.0013677576,"teacher_disagreement_score":0.0061147255,"about_ca_system_score_codex":0.0011925778,"about_ca_system_score_gemma":0.001104857,"threshold_uncertainty_score":0.016140401},"labels":[],"label_agreement":null},{"id":"W2096795054","doi":"10.1586/ehm.09.8","title":"Preventing thrombophilia-related complications of pregnancy","year":2009,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Thrombophilia; Placental abruption; Pregnancy; Preeclampsia; Obstetrics; Intrauterine growth restriction; Antiphospholipid syndrome; Venous thromboembolism; Gynecology; Fetus; Thrombosis; Internal medicine","score_opus":0.06763437100397245,"score_gpt":0.4046199351107086,"score_spread":0.33698556410673614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096795054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011670267,0.9990482,0.000056805813,0.00021515241,0.00008782889,0.000003867661,0.000009544794,0.00000404179,0.00045797258],"genre_scores_gemma":[0.00059610506,0.99888724,0.00011206459,0.000112779715,0.0000914525,0.0000049674304,0.000013975202,5.4152815e-7,0.00018086766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996898,0.00007975771,0.00004514763,0.000039703937,0.00012263846,0.000022991038],"domain_scores_gemma":[0.9996829,0.00015669907,0.00006282976,0.0000080516775,0.00006690884,0.000022713799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000668798,0.0007288616,0.0015810732,0.0018462111,0.000223086,0.0006175513,0.0007995238,0.0012012132,0.0032592616],"category_scores_gemma":[0.0010177769,0.0001974087,0.0005266678,0.0015936056,0.00029612362,0.00048843876,0.00048769976,0.0010131622,0.0017026706],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054266548,0.00007139057,0.0002741055,0.018343862,0.00017987784,0.00022132507,0.00003867828,0.00018656734,0.00079953024,0.0010608638,0.018070547,0.9606991],"study_design_scores_gemma":[0.00010216245,0.0002668687,0.0039080395,0.018763402,0.0006488885,0.0050208303,0.00011891173,0.00018326948,0.0010190799,0.0023852808,0.9675547,0.000028625962],"about_ca_topic_score_codex":0.0014373973,"about_ca_topic_score_gemma":0.0019416256,"teacher_disagreement_score":0.0032592616,"about_ca_system_score_codex":0.00043844894,"about_ca_system_score_gemma":0.0010351982,"threshold_uncertainty_score":0.010903358},"labels":[],"label_agreement":null},{"id":"W2102038897","doi":"10.1586/ehm.13.18","title":"Preventing thrombophilia-related complications of pregnancy: an update","year":2013,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Medicine; Thrombophilia; Pregnancy; Antiphospholipid syndrome; Observational study; Obstetrics; Lupus anticoagulant; Intensive care medicine; Surgery; Thrombosis; Internal medicine","score_opus":0.07406171112022669,"score_gpt":0.404382092805826,"score_spread":0.3303203816855993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102038897","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003783722,0.99920446,0.000033658387,0.000332565,0.00015042679,0.0000051232314,0.000017508048,0.0000026112311,0.00021579147],"genre_scores_gemma":[0.00019516329,0.9992648,0.0001251801,0.00020166324,0.000104905455,0.0000052587657,0.000019167353,5.692356e-7,0.00008329603],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993224,0.00014589097,0.00017998747,0.00006726378,0.00024974134,0.000034799417],"domain_scores_gemma":[0.9980767,0.0010489415,0.00029095932,0.000029264893,0.00048970344,0.00006446476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017609642,0.0009237943,0.0022015267,0.004173735,0.00029206954,0.0012080852,0.0013253865,0.0017243237,0.0038856277],"category_scores_gemma":[0.0031939535,0.00048294364,0.0014423693,0.0033590153,0.00034327514,0.0013839463,0.0007312908,0.0017107762,0.0012287357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007651992,0.00007639734,0.00021395904,0.07656117,0.00037656052,0.00015438415,0.0000734568,0.00020126655,0.00041178486,0.0013481114,0.04152456,0.87898195],"study_design_scores_gemma":[0.00007153856,0.00017383994,0.001757507,0.07115844,0.0018531788,0.0015040749,0.000114730705,0.00015290505,0.0002519058,0.001275927,0.92165166,0.000034353066],"about_ca_topic_score_codex":0.0036424552,"about_ca_topic_score_gemma":0.006529149,"teacher_disagreement_score":0.004173735,"about_ca_system_score_codex":0.0009931007,"about_ca_system_score_gemma":0.0027883307,"threshold_uncertainty_score":0.0129987},"labels":[],"label_agreement":null},{"id":"W2102066474","doi":"10.1586/ehm.10.60","title":"Philadelphia chromosome-positive acute lymphoblastic leukemia in children: new and emerging treatment options","year":2010,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"","keywords":"Medicine; Dasatinib; Philadelphia chromosome; Nilotinib; Imatinib; Oncology; Chemotherapy; Internal medicine; Acute lymphocytic leukemia; Hematopoietic stem cell transplantation; Transplantation; Imatinib mesylate; Chemotherapy regimen; Regimen; Leukemia; Lymphoblastic Leukemia; Myeloid leukemia; Chromosomal translocation","score_opus":0.019400866095464,"score_gpt":0.34919228973256367,"score_spread":0.3297914236370997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102066474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007905752,0.99885404,0.00006665957,0.00029495513,0.00008673502,0.000003007585,0.000008073201,0.000004849696,0.0006026718],"genre_scores_gemma":[0.00036110988,0.99894005,0.00014292868,0.00016483106,0.00011524194,0.0000040983487,0.000017099626,7.9871444e-7,0.00025392708],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997693,0.000058927733,0.000029000004,0.00003597072,0.0000891719,0.000017782835],"domain_scores_gemma":[0.99967265,0.00014709657,0.000055688455,0.000009022777,0.00007985536,0.000035687957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070807914,0.0008567366,0.0018601125,0.0017238656,0.00024272063,0.0008734605,0.0010341435,0.0010696393,0.004113309],"category_scores_gemma":[0.0006262097,0.00025149065,0.00045498027,0.0023675773,0.00043861425,0.0013843641,0.00058667595,0.0017170684,0.0022202968],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006063253,0.00006304401,0.00015661208,0.0076523866,0.000058718837,0.00020043374,0.000036980393,0.000269494,0.00052176235,0.001666643,0.026208106,0.9631052],"study_design_scores_gemma":[0.000069007576,0.00013805379,0.0011541366,0.0047071176,0.00014079949,0.002351116,0.00009743319,0.00015163008,0.00020027524,0.00169712,0.9892755,0.000017884468],"about_ca_topic_score_codex":0.0013736037,"about_ca_topic_score_gemma":0.0036057488,"teacher_disagreement_score":0.004113309,"about_ca_system_score_codex":0.00060860644,"about_ca_system_score_gemma":0.0009799266,"threshold_uncertainty_score":0.013760388},"labels":[],"label_agreement":null},{"id":"W2105235256","doi":"10.1586/17474086.2013.827413","title":"Practical management of patients with myelofibrosis receiving ruxolitinib","year":2013,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Adverse effect; Extramedullary hematopoiesis; Anemia; Constitutional symptoms; Internal medicine; Randomized controlled trial; Clinical trial; Intensive care medicine; Bone marrow; Oncology; Disease; Haematopoiesis; Stem cell","score_opus":0.048357737867579915,"score_gpt":0.39484366910145563,"score_spread":0.3464859312338757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105235256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046121122,0.9975936,0.00019014497,0.00042898653,0.00009747406,0.000012560884,0.000018728108,0.0000074727086,0.0011897925],"genre_scores_gemma":[0.003389095,0.9948394,0.000541714,0.00040582372,0.00018288053,0.000016789574,0.000058951096,0.0000012923416,0.00056395703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985516,0.000044536766,0.000029775365,0.000013367899,0.000045736113,0.000011316898],"domain_scores_gemma":[0.99987686,0.00004861767,0.00003377908,0.0000023939376,0.000028352295,0.000010002014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003480623,0.00048482875,0.0009994798,0.0009716543,0.00019013447,0.00042207632,0.0006081776,0.0006896079,0.00198457],"category_scores_gemma":[0.0006361809,0.00012737163,0.00042842384,0.0006716167,0.0001266113,0.0004726936,0.00034963054,0.00087299116,0.0008889955],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009264873,0.000062094965,0.0003784326,0.014613132,0.00012846319,0.00062905345,0.000073937124,0.00020496354,0.0011767343,0.00073954155,0.023993239,0.95790774],"study_design_scores_gemma":[0.00019844611,0.00027290036,0.0069008353,0.01742897,0.0005780509,0.014028323,0.00030323697,0.00034201448,0.0012997031,0.0019468282,0.956656,0.00004470046],"about_ca_topic_score_codex":0.0007258391,"about_ca_topic_score_gemma":0.0018981536,"teacher_disagreement_score":0.00198457,"about_ca_system_score_codex":0.00021520576,"about_ca_system_score_gemma":0.0005144819,"threshold_uncertainty_score":0.0066390634},"labels":[],"label_agreement":null},{"id":"W2111763904","doi":"10.1586/ehm.11.45","title":"Platelet-type von Willebrand disease update: the disease, the molecule and the animal model","year":2011,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Platelet; Von Willebrand disease; Platelet membrane glycoprotein; Glycoprotein; Von Willebrand factor; Disease; Immunology; Platelet Glycoprotein GPIb-IX Complex; Platelet disorder; Internal medicine; Molecular biology; Biology","score_opus":0.010869868000023639,"score_gpt":0.2962629254472423,"score_spread":0.28539305744721866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111763904","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008037612,0.14242828,0.00025885078,0.039373524,0.81540877,0.000019515199,0.00006593563,0.0000657381,0.0022991125],"genre_scores_gemma":[0.00058352796,0.1330746,0.00028472274,0.030787805,0.82530826,0.000024025623,0.00008767413,0.000030206527,0.0098191975],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986609,0.00030611406,0.00021542578,0.000120215656,0.00061656366,0.00008074],"domain_scores_gemma":[0.9941385,0.0025614013,0.0004515534,0.000107695036,0.0020815667,0.0006593775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033601136,0.002362553,0.0028481404,0.0021422084,0.0010435142,0.002968738,0.0021336551,0.0070575173,0.005885258],"category_scores_gemma":[0.0065047718,0.00068204314,0.0014465628,0.0012562812,0.001225408,0.0031827602,0.0008802158,0.010828542,0.0070982734],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035709993,0.00001148675,0.000017732062,0.0003679976,0.000016875574,0.00009540499,0.000007975357,0.000020454043,0.00006961484,0.0003003078,0.9855062,0.013550204],"study_design_scores_gemma":[0.00005947582,0.00003958122,0.00014494719,0.0006510831,0.00006479225,0.0006353639,0.000023712531,0.00007895303,0.00007737442,0.0005782641,0.99763465,0.0000117377485],"about_ca_topic_score_codex":0.0010086548,"about_ca_topic_score_gemma":0.0038796624,"teacher_disagreement_score":0.0070575173,"about_ca_system_score_codex":0.0014404038,"about_ca_system_score_gemma":0.0017239378,"threshold_uncertainty_score":0.01968813},"labels":[],"label_agreement":null},{"id":"W2114583616","doi":"10.1586/17474086.2014.951322","title":"Alprolix (recombinant Factor IX Fc fusion protein): extended half-life product for the prophylaxis and treatment of hemophilia B","year":2014,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Factor IX; Recombinant DNA; Genetic enhancement; Fusion protein; Coagulation; Disease; Internal medicine; Immunology; Pharmacology; Gene","score_opus":0.03703268248659912,"score_gpt":0.35180181884704737,"score_spread":0.31476913636044823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114583616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011499504,0.9888536,0.0008701059,0.0014738523,0.0006677412,0.000025908552,0.000044317905,0.000030111707,0.0068844473],"genre_scores_gemma":[0.010971022,0.97415775,0.0017049006,0.0016901188,0.0012799272,0.000038092207,0.00017766132,0.000012004708,0.009968527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997203,0.000056755787,0.00002085507,0.00004275389,0.00013847425,0.000020815845],"domain_scores_gemma":[0.9997186,0.000093909206,0.000069966125,0.000007721611,0.00007514435,0.00003452984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006977232,0.0004555195,0.00065734476,0.0012201297,0.0001894535,0.0006294613,0.0005640693,0.0011745704,0.0035521884],"category_scores_gemma":[0.0005469507,0.00009481313,0.00032880675,0.00087858306,0.00031804747,0.00042803257,0.0002648836,0.0010781212,0.0032180408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015924525,0.00013820644,0.00030479897,0.0029405649,0.00008001193,0.0003799581,0.000048950023,0.00015796215,0.0074581783,0.0032943983,0.052022252,0.9330155],"study_design_scores_gemma":[0.00009270953,0.00025603903,0.00087020063,0.0005952473,0.00006266093,0.0032257792,0.000026273487,0.00006206388,0.0024500093,0.0006921703,0.99165523,0.000011694747],"about_ca_topic_score_codex":0.0005453307,"about_ca_topic_score_gemma":0.0008191282,"teacher_disagreement_score":0.0035521884,"about_ca_system_score_codex":0.00039848936,"about_ca_system_score_gemma":0.00049981463,"threshold_uncertainty_score":0.011883259},"labels":[],"label_agreement":null},{"id":"W2115740244","doi":"10.1586/ehm.10.68","title":"Older patients with acute myeloid leukemia","year":2010,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myeloid leukemia; Disease; Oncology; Tolerability; Induction chemotherapy; Clinical trial; Internal medicine; Chemotherapy; Intensive care medicine; Adverse effect","score_opus":0.020115558474148244,"score_gpt":0.363715221955897,"score_spread":0.34359966348174875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115740244","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021800198,0.9983859,0.000061661,0.00030439245,0.00015044998,0.000006227254,0.000019402694,0.0000039066317,0.0008501677],"genre_scores_gemma":[0.0015652665,0.9971493,0.0001118004,0.00029618296,0.00019620344,0.000011601019,0.000052815554,7.612703e-7,0.0006160424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978346,0.000054106848,0.000034830013,0.00003353693,0.00007479958,0.000019323084],"domain_scores_gemma":[0.9997551,0.00009010403,0.00006478838,0.000006567914,0.00005956979,0.00002378928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046909053,0.0007815403,0.0017828743,0.0010300992,0.0002539953,0.00065451476,0.0005878536,0.00076442276,0.0036672852],"category_scores_gemma":[0.0008664886,0.00014003261,0.00047885632,0.0013384643,0.00022380461,0.0007309821,0.000525884,0.00079973415,0.002181534],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006963763,0.000038615068,0.0007302323,0.011176891,0.00012298345,0.000177394,0.000054514687,0.000083317835,0.0005618853,0.0006871084,0.03143246,0.954865],"study_design_scores_gemma":[0.00007027388,0.00018549166,0.0066888123,0.011074634,0.00045221663,0.004719995,0.00017108985,0.000067550485,0.00037161628,0.0012729522,0.97490215,0.000023283566],"about_ca_topic_score_codex":0.0010642126,"about_ca_topic_score_gemma":0.0021309745,"teacher_disagreement_score":0.0036672852,"about_ca_system_score_codex":0.0003249593,"about_ca_system_score_gemma":0.0007895777,"threshold_uncertainty_score":0.012268305},"labels":[],"label_agreement":null},{"id":"W2116119814","doi":"10.1586/ehm.12.56","title":"Clinical causes and treatment of the thrombotic storm","year":2012,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Catastrophic antiphospholipid syndrome; Thrombosis; Antiphospholipid syndrome; Thrombophilia; Coagulopathy; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.11783865859256074,"score_gpt":0.4478899808725514,"score_spread":0.3300513222799907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116119814","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027330845,0.99750817,0.0002227441,0.00041143515,0.00015763305,0.0000051355855,0.000014229372,0.0000078880585,0.00139952],"genre_scores_gemma":[0.0031944897,0.9950263,0.0003329189,0.00037804624,0.00043421285,0.000008270903,0.000055343156,0.0000023506298,0.00056800654],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975914,0.00005505782,0.00003892091,0.000038937982,0.00008785855,0.000020017253],"domain_scores_gemma":[0.9997764,0.000089905196,0.000053072148,0.000008492644,0.000048389884,0.000023775136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035433398,0.0006392212,0.0012529023,0.0017460546,0.00022814813,0.0007649951,0.00078612874,0.00093973253,0.0023895476],"category_scores_gemma":[0.00085726863,0.00014917436,0.0003607439,0.0010414281,0.000390283,0.0005990032,0.00038063436,0.0014310273,0.0016243529],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058881986,0.00007458673,0.0005401983,0.007864695,0.00007980641,0.0017146557,0.00005423201,0.00025961845,0.0013198219,0.0022847853,0.028600415,0.95714843],"study_design_scores_gemma":[0.00007295991,0.00014834564,0.0041072927,0.011139502,0.0002470814,0.04963766,0.00020618549,0.0003063138,0.0017872966,0.0058301343,0.9264821,0.00003516381],"about_ca_topic_score_codex":0.0004936939,"about_ca_topic_score_gemma":0.00078892644,"teacher_disagreement_score":0.0023895476,"about_ca_system_score_codex":0.00036161454,"about_ca_system_score_gemma":0.00058275973,"threshold_uncertainty_score":0.007993817},"labels":[],"label_agreement":null},{"id":"W2118890264","doi":"10.1586/17474086.2015.978281","title":"Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention","year":2014,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Lymphoblastic Leukemia; Disease; Intensive care medicine; Oncology; Pediatrics; Internal medicine; Leukemia","score_opus":0.020466678903095628,"score_gpt":0.35586712279538013,"score_spread":0.3354004438922845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118890264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008397536,0.9988237,0.00010710366,0.00048053914,0.00011752182,0.000004247731,0.000020154623,0.000004516105,0.00035818128],"genre_scores_gemma":[0.0006472802,0.99872655,0.00018642514,0.00013324208,0.00014338247,0.000005546419,0.000030951847,7.80265e-7,0.00012580122],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996562,0.00009874698,0.000058264613,0.00005148262,0.00011424076,0.000021053258],"domain_scores_gemma":[0.9992048,0.00045148525,0.00012669638,0.000016282207,0.00016589173,0.000034786626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010864437,0.00075990916,0.0016644043,0.002113359,0.00021031058,0.0010000651,0.0009873958,0.0009192703,0.0023051098],"category_scores_gemma":[0.0019813257,0.00022536369,0.0008989987,0.0015757123,0.00038932092,0.0008150844,0.0005854392,0.0017948946,0.0011135426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058644167,0.0000517887,0.0009272584,0.010719295,0.00020222449,0.000110933164,0.00004181875,0.0002601003,0.00020545884,0.0018099414,0.017252276,0.9683602],"study_design_scores_gemma":[0.00006430276,0.00026201206,0.007238609,0.033398245,0.0012471871,0.0029206849,0.00023285687,0.00040368037,0.0005549102,0.0063087577,0.9472976,0.000071191535],"about_ca_topic_score_codex":0.0020765697,"about_ca_topic_score_gemma":0.00281964,"teacher_disagreement_score":0.0023051098,"about_ca_system_score_codex":0.0006257691,"about_ca_system_score_gemma":0.0013324769,"threshold_uncertainty_score":0.0077114105},"labels":[],"label_agreement":null},{"id":"W2122385972","doi":"10.1586/17474086.2013.842124","title":"Thrombosis in pediatric cancer: identifying the risk factors to improve care","year":2013,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Asymptomatic; Cancer; Pediatric cancer; Intensive care medicine; Pediatrics; Thrombosis; Complication; Childhood cancer; Population; Surgery; Internal medicine; Environmental health","score_opus":0.050631895932307845,"score_gpt":0.4054087468857177,"score_spread":0.3547768509534099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122385972","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009679112,0.99793744,0.0001584338,0.0009045013,0.00019307937,0.0000050327017,0.000022131857,0.000006994195,0.00067567715],"genre_scores_gemma":[0.0006571282,0.99843365,0.00026052116,0.00022386457,0.00021495527,0.000005550728,0.000035995505,0.0000010428097,0.00016721601],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997204,0.00007210919,0.00004968045,0.0000382508,0.00009858085,0.000020970709],"domain_scores_gemma":[0.99942386,0.00027933836,0.00009891705,0.000011952611,0.0001475245,0.000038549442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057985424,0.00073442067,0.001193551,0.0021805386,0.00023426645,0.000863354,0.0007608341,0.0010196427,0.0034853348],"category_scores_gemma":[0.0017722667,0.00019086794,0.00063253316,0.0017284531,0.0002605233,0.0010759834,0.00053395564,0.0017479847,0.0013954431],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003330545,0.000052720065,0.0009217981,0.016596694,0.0001323499,0.00029506302,0.00006419517,0.00024309767,0.0003231005,0.0020181164,0.04694939,0.9323702],"study_design_scores_gemma":[0.00004096316,0.00009850336,0.0044340994,0.02724937,0.00046489044,0.005145542,0.00022487108,0.00027666264,0.00032980478,0.0032200885,0.9584816,0.000033598535],"about_ca_topic_score_codex":0.0020866732,"about_ca_topic_score_gemma":0.0028551857,"teacher_disagreement_score":0.0034853348,"about_ca_system_score_codex":0.0006030992,"about_ca_system_score_gemma":0.0015666418,"threshold_uncertainty_score":0.011659563},"labels":[],"label_agreement":null},{"id":"W2134879438","doi":"10.1586/ehm.11.41","title":"Inherited platelet disorders: a clinical approach to diagnosis and management","year":2011,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Platelet; Platelet disorder; Blood Platelet Disorders; Mucocutaneous zone; Immunology; Pathology; Intensive care medicine; Bioinformatics; Disease; Platelet aggregation","score_opus":0.09485437774920512,"score_gpt":0.41991313772120553,"score_spread":0.3250587599720004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134879438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048117782,0.9867487,0.0025282956,0.0041342946,0.0008756513,0.000031208747,0.000030809966,0.00004399691,0.005125926],"genre_scores_gemma":[0.004539616,0.9848513,0.0043266797,0.0018858716,0.0022916903,0.00004282952,0.000082628125,0.000005709507,0.0019736548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996371,0.0000898009,0.0000616613,0.000042035565,0.00014556454,0.000023749459],"domain_scores_gemma":[0.9997166,0.00008418624,0.000045849203,0.000008493075,0.00010535873,0.00003954443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056677335,0.0011474284,0.0012526726,0.0022578398,0.00036828246,0.0009801572,0.0011008128,0.0016989529,0.0021650686],"category_scores_gemma":[0.0009984171,0.00020102525,0.0003717221,0.0015048584,0.000618967,0.0011297292,0.0008202693,0.0025039848,0.0018568718],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048435213,0.00011243421,0.0009926155,0.004026376,0.000066668326,0.006947522,0.00019144116,0.00052270567,0.0015811567,0.005611889,0.09564335,0.88425535],"study_design_scores_gemma":[0.00006331989,0.00017391852,0.0034731068,0.009550014,0.00016403657,0.10039543,0.0004949745,0.00055807683,0.00068027107,0.012497586,0.8718859,0.00006336731],"about_ca_topic_score_codex":0.0009555207,"about_ca_topic_score_gemma":0.0015560663,"teacher_disagreement_score":0.0022578398,"about_ca_system_score_codex":0.00072244386,"about_ca_system_score_gemma":0.0011078322,"threshold_uncertainty_score":0.007242918},"labels":[],"label_agreement":null},{"id":"W2137678379","doi":"10.1586/ehm.10.15","title":"Hemophilia: basic and translational science","year":2010,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Session (web analytics); Hemostasis; Translational research; Translational science; Internal medicine; Pathology","score_opus":0.02436481757706234,"score_gpt":0.37643952530807245,"score_spread":0.35207470773101013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137678379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021445637,0.8354573,0.0041293064,0.1017752,0.01621006,0.0002662291,0.0004174001,0.00014873265,0.03945126],"genre_scores_gemma":[0.023046372,0.9000689,0.0059125614,0.016957948,0.0378615,0.0003060832,0.0009842932,0.00003798514,0.014824321],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900776,0.000366901,0.00009005214,0.00007201307,0.00035946697,0.00010385539],"domain_scores_gemma":[0.99731404,0.00095953874,0.0001879622,0.00023108503,0.00076279993,0.000544619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066770036,0.0004785796,0.00085201487,0.0009799541,0.0004249407,0.0021645094,0.00061099016,0.0022021562,0.014615512],"category_scores_gemma":[0.0035795728,0.00020435428,0.0002994704,0.0010497001,0.00095633534,0.0015484699,0.0008507509,0.00315742,0.0055746045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024940143,0.00027289984,0.0007002792,0.003452458,0.000049347138,0.00034033472,0.00016513851,0.00010754625,0.0056652147,0.021167291,0.21386456,0.7539655],"study_design_scores_gemma":[0.00008761121,0.0003853478,0.0020642723,0.0016796114,0.00003640609,0.0011775855,0.0001345066,0.00011104962,0.0018251649,0.011654556,0.98082596,0.00001792421],"about_ca_topic_score_codex":0.0004135236,"about_ca_topic_score_gemma":0.00043199543,"teacher_disagreement_score":0.014615512,"about_ca_system_score_codex":0.0011215423,"about_ca_system_score_gemma":0.0037437326,"threshold_uncertainty_score":0.04889375},"labels":[],"label_agreement":null},{"id":"W2139055966","doi":"10.1586/17474086.2013.841538","title":"Bendamustine for indolent non-Hodgkin lymphoma in the front-line or relapsed setting: a review of pharmacokinetics and clinical trial outcomes","year":2013,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Bendamustine; Medicine; Tolerability; Clinical trial; Oncology; Pharmacokinetics; Refractory (planetary science); Pharmacology; Internal medicine; Lymphoma; Rituximab; Adverse effect","score_opus":0.11394806879692908,"score_gpt":0.4874092623334129,"score_spread":0.3734611935364838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139055966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012132886,0.99926704,0.000049010865,0.00015128707,0.000053311815,0.000007306251,0.000020401523,0.0000032817327,0.0003269983],"genre_scores_gemma":[0.00071252073,0.99875224,0.0001419448,0.00015109484,0.00005981781,0.000008704547,0.000030129815,0.0000011164987,0.00014252562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997538,0.000054756172,0.0000627955,0.000038486778,0.00007427306,0.000015931444],"domain_scores_gemma":[0.999302,0.00037387843,0.0001319267,0.000011935106,0.00014449903,0.000035774003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010406025,0.0006469508,0.0019553923,0.0017928128,0.00020710281,0.0007702594,0.00094250013,0.00071706116,0.0037000955],"category_scores_gemma":[0.0014141378,0.00024462293,0.0009485468,0.0021533843,0.00025956455,0.0009303604,0.0004492893,0.0010408092,0.000848179],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002218344,0.0000800527,0.0002048366,0.046876036,0.00031308184,0.00014984938,0.00004662082,0.00028265535,0.0009998226,0.0009327356,0.017255142,0.9326375],"study_design_scores_gemma":[0.00026359936,0.00071458437,0.0026098357,0.03910849,0.0022979127,0.0028063771,0.00013838931,0.00028663123,0.0009460667,0.0016902003,0.9490865,0.0000515778],"about_ca_topic_score_codex":0.00085695134,"about_ca_topic_score_gemma":0.0021996996,"teacher_disagreement_score":0.0037000955,"about_ca_system_score_codex":0.0005892824,"about_ca_system_score_gemma":0.0011612534,"threshold_uncertainty_score":0.012378097},"labels":[],"label_agreement":null},{"id":"W2144345143","doi":"10.1586/ehm.09.23","title":"Iron overload in myelodysplastic syndromes","year":2009,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Intensive care medicine; Internal medicine; Bone marrow","score_opus":0.009037749780192532,"score_gpt":0.32531710460791313,"score_spread":0.3162793548277206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144345143","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059055565,0.041253008,0.00021157044,0.025209023,0.9319801,0.000021895972,0.000040290528,0.000051339543,0.0011736803],"genre_scores_gemma":[0.00049195584,0.02144413,0.00020827386,0.020977365,0.95230055,0.000023010112,0.000031538322,0.000017498678,0.004505626],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974468,0.0005949176,0.0004869957,0.00024905137,0.0010587242,0.00016346043],"domain_scores_gemma":[0.9904351,0.0036457547,0.0007510762,0.00020020486,0.0037849648,0.0011829691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00511298,0.0032436114,0.0049927314,0.0035183828,0.0017323978,0.0037304831,0.0032702812,0.012797185,0.0052724187],"category_scores_gemma":[0.011562879,0.0010996504,0.0023860035,0.0013761019,0.0014941237,0.0024586467,0.0013352341,0.013451459,0.004881302],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058780515,0.00001682942,0.000039670565,0.0005265509,0.000046273115,0.00020326124,0.000010173379,0.00002368404,0.00006101187,0.00013365305,0.98838556,0.010494571],"study_design_scores_gemma":[0.00026205168,0.000079648315,0.0006875533,0.0013217514,0.00031137813,0.001205509,0.000038646984,0.00029602592,0.00017944984,0.0006093197,0.99497485,0.00003374021],"about_ca_topic_score_codex":0.0016136349,"about_ca_topic_score_gemma":0.0049493103,"teacher_disagreement_score":0.012797185,"about_ca_system_score_codex":0.0020884194,"about_ca_system_score_gemma":0.0019407333,"threshold_uncertainty_score":0.027040303},"labels":[],"label_agreement":null},{"id":"W2154259107","doi":"10.1586/17474086.2015.995623","title":"In the realms of future: new frontiers of ‘techno-oncology’ as a platform for global improvement in the outcomes of childhood cancer","year":2014,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"","keywords":"Medicine; Pace; Childhood cancer; Scope (computer science); Developing country; Pediatric oncology; Cancer; Oncology; Economic growth; Internal medicine","score_opus":0.015479382834199166,"score_gpt":0.38650303567240335,"score_spread":0.3710236528382042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154259107","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044895467,0.07296678,0.00018326793,0.10090343,0.82440704,0.000010046233,0.000019420382,0.00003796156,0.0014271921],"genre_scores_gemma":[0.000518511,0.04214297,0.00015058959,0.046359975,0.9066326,0.000013044647,0.0000148662875,0.000025557089,0.004141842],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99488336,0.0015317568,0.0005226594,0.00045894936,0.0023235022,0.00027973647],"domain_scores_gemma":[0.97872555,0.013570243,0.0008679192,0.00038567436,0.004756771,0.0016937674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007673655,0.0026912957,0.0028731837,0.0021252604,0.002282371,0.0069654942,0.003320234,0.014008533,0.005299793],"category_scores_gemma":[0.021680888,0.00086238876,0.0020871945,0.0012958414,0.0041003576,0.0077755973,0.0018098734,0.031656552,0.004449651],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001618913,0.000011736155,0.000028897424,0.00040766576,0.000019722896,0.00007245169,0.000054186654,0.0000314559,0.000045206216,0.0011499271,0.9846395,0.013523049],"study_design_scores_gemma":[0.000026016298,0.00003005289,0.00016732512,0.00075344404,0.000036194226,0.00028563384,0.000108113614,0.00007636471,0.000056127024,0.002633893,0.9958072,0.000019583336],"about_ca_topic_score_codex":0.0016059735,"about_ca_topic_score_gemma":0.0047221775,"teacher_disagreement_score":0.014008533,"about_ca_system_score_codex":0.0033828716,"about_ca_system_score_gemma":0.0042420425,"threshold_uncertainty_score":0.040582657},"labels":[],"label_agreement":null},{"id":"W2159451755","doi":"10.1586/17474086.2013.859520","title":"1:1:1 – Warranted or wasteful? Even where appropriate, high ratio transfusion protocols are costly: early transition to individualized care benefits patients and transfusion services","year":2013,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Intensive care medicine; Blood transfusion; Surgery","score_opus":0.013558157180038591,"score_gpt":0.31263003160428343,"score_spread":0.2990718744242448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159451755","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049444243,0.038584046,0.0002001293,0.06918148,0.89062065,0.000017644017,0.000039020884,0.000046347417,0.0012612678],"genre_scores_gemma":[0.00064498256,0.03910215,0.00025726724,0.053499643,0.90213853,0.000021432526,0.000026277117,0.000036583726,0.004273082],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961826,0.0009911897,0.0006843446,0.0003785525,0.0015710886,0.00019209427],"domain_scores_gemma":[0.9819125,0.01034082,0.0012054006,0.00030807723,0.0051993043,0.0010338892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065351618,0.0022276528,0.0030872314,0.0015778743,0.0018341751,0.004511617,0.0024768657,0.009675876,0.005550578],"category_scores_gemma":[0.02752763,0.0007169101,0.001602018,0.001114367,0.002655189,0.004112881,0.00094487105,0.018285502,0.005476388],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034139524,0.000009296334,0.000026973124,0.00046363534,0.00002692396,0.00009963153,0.000016495527,0.000019456975,0.00004672037,0.000451056,0.98688173,0.01192401],"study_design_scores_gemma":[0.00006524396,0.00003603915,0.00021202707,0.0013789136,0.000104911465,0.0005178897,0.000060103324,0.00009249262,0.0001593352,0.0015826415,0.99576604,0.000024383426],"about_ca_topic_score_codex":0.0013121451,"about_ca_topic_score_gemma":0.0032806308,"teacher_disagreement_score":0.009675876,"about_ca_system_score_codex":0.0018232681,"about_ca_system_score_gemma":0.0026871264,"threshold_uncertainty_score":0.034561634},"labels":[],"label_agreement":null},{"id":"W2161640233","doi":"10.1586/ehm.11.27","title":"Biomarkers in chronic graft-versus-host disease","year":2011,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Disease; Hematopoietic stem cell transplantation; Graft-versus-host disease; Pathophysiology; Immunology; Intensive care medicine; Bioinformatics; Immune system; Transplantation; Pathology; Internal medicine; Biology","score_opus":0.05880769473109391,"score_gpt":0.38881828105228394,"score_spread":0.33001058632119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161640233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008389254,0.9988545,0.00009621153,0.0003518466,0.00019470493,0.0000030219508,0.000009377441,0.0000035697415,0.0004028373],"genre_scores_gemma":[0.0009407755,0.99788684,0.0002434923,0.00029205283,0.00028322637,0.000007664804,0.000024146484,9.30168e-7,0.00032087602],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959606,0.00010225377,0.000064103304,0.00005181554,0.00015884356,0.000026944352],"domain_scores_gemma":[0.9992459,0.0003609835,0.00012635226,0.000017165423,0.00020941462,0.000040153995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011004689,0.0009918625,0.0020073461,0.002672875,0.00028700836,0.0012204134,0.0009274097,0.0016784655,0.0020439024],"category_scores_gemma":[0.0013407985,0.00024277248,0.0006587728,0.0026360957,0.00067385007,0.0013532824,0.00061171275,0.0019862696,0.0015826283],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011034968,0.00008275513,0.00089897675,0.0123566,0.00016512974,0.00050770806,0.000060148992,0.00024138264,0.0018291406,0.0034079552,0.033537764,0.946802],"study_design_scores_gemma":[0.000051616673,0.00018075154,0.0038372595,0.008828686,0.00033072638,0.0065794005,0.00015452142,0.00020794914,0.0015605098,0.0057417806,0.9724768,0.000050102884],"about_ca_topic_score_codex":0.000990995,"about_ca_topic_score_gemma":0.0013472514,"teacher_disagreement_score":0.002672875,"about_ca_system_score_codex":0.00069149275,"about_ca_system_score_gemma":0.0009724901,"threshold_uncertainty_score":0.006837547},"labels":[],"label_agreement":null},{"id":"W2314236616","doi":"10.1586/ehm.11.65","title":"Stem cells and beyond: report on the 40th Annual Scientific Meeting of the International Society of Experimental Hematology","year":2011,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stem cell; Haematopoiesis; Hematology; Stem cell biology; Context (archaeology); Medicine; Internal medicine; Biology; Genetics; Gene","score_opus":0.03806977854366482,"score_gpt":0.3371279983015401,"score_spread":0.2990582197578753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314236616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005787272,0.6133006,0.0020243328,0.11480514,0.21925807,0.0006318284,0.002716895,0.00014337279,0.041332424],"genre_scores_gemma":[0.022892196,0.5903997,0.0030399805,0.04057114,0.13180521,0.000668952,0.005972725,0.00013996878,0.20451005],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977912,0.00022305093,0.00011594209,0.00021524144,0.0011112341,0.00054334616],"domain_scores_gemma":[0.9960091,0.00041962243,0.00022544498,0.00007526569,0.0019196314,0.0013508265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070286947,0.0016927192,0.001215814,0.0021790473,0.0010789735,0.0038860617,0.0011902105,0.0049633235,0.013637021],"category_scores_gemma":[0.0026025465,0.00041400283,0.0010236991,0.0016867219,0.0007888656,0.0023542228,0.0023993135,0.0036245205,0.0062027965],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053926307,0.00018332155,0.0007435474,0.0009096018,0.000054446937,0.0002402188,0.00008086902,0.00017030913,0.0039106584,0.002242262,0.8855617,0.10536384],"study_design_scores_gemma":[0.000038398826,0.00013410409,0.001402538,0.00025186877,0.000048371716,0.00008200018,0.000075907745,0.000059991762,0.0019248062,0.0006543682,0.9953082,0.000019298332],"about_ca_topic_score_codex":0.003130882,"about_ca_topic_score_gemma":0.0052728034,"teacher_disagreement_score":0.013637021,"about_ca_system_score_codex":0.0021527614,"about_ca_system_score_gemma":0.0060506156,"threshold_uncertainty_score":0.04562044},"labels":[],"label_agreement":null},{"id":"W2417014160","doi":"10.1080/17474086.2016.1198895","title":"Thrombotic thrombocytopenic pupura (TTP) dinner symposium proceedings","year":2016,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Thrombotic thrombocytopenic purpura; Medicine; Intensive care medicine; Alternative medicine; Thrombosis; Family medicine; Immunology; Internal medicine; Platelet; Pathology","score_opus":0.01774118943159769,"score_gpt":0.30316098061953295,"score_spread":0.28541979118793526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417014160","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006543515,0.32899892,0.0016490279,0.23479873,0.29075316,0.0004458847,0.00093132636,0.00028919076,0.1355902],"genre_scores_gemma":[0.048276987,0.31953928,0.0027967663,0.07488547,0.14738081,0.00038103876,0.0026259497,0.00013468212,0.403979],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994541,0.00013328409,0.000037927035,0.000056515746,0.0002047139,0.000113600196],"domain_scores_gemma":[0.9986474,0.00013541663,0.000085684966,0.00002486977,0.00045902253,0.0006476071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017656712,0.0006434994,0.0006096201,0.0006796385,0.0008906246,0.0016687807,0.00060669816,0.0031007964,0.025799043],"category_scores_gemma":[0.0021555976,0.00018868479,0.00060239347,0.0002894273,0.00043136827,0.0006629188,0.0014639045,0.0033004438,0.008733223],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015431565,0.00006415459,0.00032465506,0.0002801655,0.000022968541,0.00045258677,0.00004273303,0.000039202703,0.0005305963,0.0012605735,0.93180925,0.06501871],"study_design_scores_gemma":[0.000037646063,0.00011428816,0.0010474891,0.0004530326,0.000019844249,0.0008075263,0.00008765033,0.000030505122,0.00027886266,0.00062533136,0.99648947,0.000008398545],"about_ca_topic_score_codex":0.0023633882,"about_ca_topic_score_gemma":0.0069023995,"teacher_disagreement_score":0.025799043,"about_ca_system_score_codex":0.0011680445,"about_ca_system_score_gemma":0.0016512587,"threshold_uncertainty_score":0.08630639},"labels":[],"label_agreement":null},{"id":"W2464396699","doi":"10.1080/17474086.2016.1208555","title":"Hematological disorders: a commonly unrecognized cause of acute stroke","year":2016,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heart and Stroke Foundation of Canada; American Heart Association","keywords":"Medicine; Stroke (engine); Etiology; Disease; Intensive care medicine; Venous thrombosis; Complication; Thrombosis; Pediatrics; Vascular disease; Internal medicine","score_opus":0.04934048004836651,"score_gpt":0.40804430130253555,"score_spread":0.35870382125416905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464396699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030775883,0.9955544,0.00014587425,0.0014392042,0.0005058383,0.000009106418,0.000093821676,0.000011859328,0.001932062],"genre_scores_gemma":[0.002620164,0.99550396,0.0001735562,0.00060106965,0.00051007106,0.0000062076147,0.00009969364,0.0000018636489,0.00048337487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961287,0.00008475063,0.00007329228,0.000061770814,0.00013575712,0.000031670177],"domain_scores_gemma":[0.99931324,0.0002929809,0.00016742367,0.000014077923,0.0001807592,0.00003162082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004672993,0.00048837846,0.00091315387,0.0016687171,0.00027512404,0.0008534149,0.0005241872,0.00085026625,0.0047304546],"category_scores_gemma":[0.0018841416,0.00013554405,0.0005508187,0.0016043603,0.0002987683,0.0006676548,0.00038980783,0.0010323003,0.0015295962],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009114117,0.000028303424,0.0015014514,0.028005293,0.00029037372,0.0008356995,0.00013166727,0.0001991276,0.0007268248,0.0024384817,0.092341065,0.8734106],"study_design_scores_gemma":[0.000033877554,0.00008065383,0.0047936416,0.03280252,0.000585222,0.012928147,0.00025499807,0.00013438979,0.0004879869,0.0027800081,0.94508165,0.000036899823],"about_ca_topic_score_codex":0.0017509102,"about_ca_topic_score_gemma":0.0027004788,"teacher_disagreement_score":0.0047304546,"about_ca_system_score_codex":0.00038304704,"about_ca_system_score_gemma":0.0014645724,"threshold_uncertainty_score":0.015824974},"labels":[],"label_agreement":null},{"id":"W2518117171","doi":"10.1080/17474086.2016.1232163","title":"Ponatinib in the therapy of chronic myeloid leukemia","year":2016,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Ponatinib; Medicine; Magic bullet; Myeloid leukemia; Targeted therapy; Disease; Oncology; Tyrosine-kinase inhibitor; Nilotinib; Internal medicine; Immunology; Bioinformatics; Imatinib; Cancer","score_opus":0.0426814344624905,"score_gpt":0.38783313961551064,"score_spread":0.3451517051530201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518117171","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016531035,0.9967187,0.000066918044,0.0011041489,0.00033875744,0.0000047251565,0.000022915758,0.0000062150234,0.0015722391],"genre_scores_gemma":[0.0024368004,0.9952141,0.0001023009,0.00071877765,0.00038657823,0.000006306577,0.0000452048,0.0000014867427,0.0010884632],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979204,0.00004992154,0.00002825286,0.00003474548,0.000077695935,0.000017350512],"domain_scores_gemma":[0.99986696,0.00005351942,0.00002959984,0.000003015382,0.00003485479,0.000012098636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033740106,0.00035471303,0.00076167093,0.0009789831,0.00020585328,0.00061421987,0.0005283721,0.00072462443,0.0040510856],"category_scores_gemma":[0.00056101946,0.00010766275,0.0003871399,0.0009130364,0.0002868486,0.0006804201,0.0004395927,0.0014290329,0.0016671179],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010808098,0.00003777172,0.00014043349,0.016589733,0.00009810572,0.00026899084,0.00006514602,0.00031220895,0.0011890843,0.004336395,0.059190586,0.9176635],"study_design_scores_gemma":[0.000038074708,0.00007114472,0.00036421718,0.002494054,0.00007297377,0.0016810079,0.000032205106,0.0000640882,0.00030531207,0.0018915595,0.9929755,0.000009999385],"about_ca_topic_score_codex":0.0006550224,"about_ca_topic_score_gemma":0.0016352105,"teacher_disagreement_score":0.0040510856,"about_ca_system_score_codex":0.0004393763,"about_ca_system_score_gemma":0.00067356817,"threshold_uncertainty_score":0.0135522485},"labels":[],"label_agreement":null},{"id":"W2526857253","doi":"10.1080/17474086.2016.1242404","title":"Immune checkpoint inhibitors in Hodgkin and non-Hodgkin lymphoma: how they work and when to use them","year":2016,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Medicine; Hodgkin lymphoma; Lymphoma; Immune system; Non-Hodgkin's lymphoma; Cancer research; Immunology; Immune checkpoint; Oncology; Immunotherapy","score_opus":0.014657470093788282,"score_gpt":0.29658655355149294,"score_spread":0.2819290834577047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526857253","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006455223,0.14081836,0.00019941939,0.055552233,0.80155957,0.000027794511,0.000060698483,0.000058371945,0.0016589937],"genre_scores_gemma":[0.0005948485,0.08989189,0.00029478266,0.0437811,0.8589398,0.000032392232,0.00005587436,0.000031852713,0.0063774483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964742,0.00088332605,0.0006733407,0.00027639925,0.0014642038,0.0002286043],"domain_scores_gemma":[0.9867914,0.005332363,0.0012880835,0.00022740167,0.0049394695,0.0014212511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063916296,0.0021423001,0.0039953794,0.0023358404,0.0011465565,0.0043765903,0.0027697086,0.010422951,0.0057178987],"category_scores_gemma":[0.016947486,0.00080797274,0.0022656065,0.0010995478,0.0013353976,0.0040388736,0.0011697893,0.014292014,0.00506652],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005455083,0.000016020318,0.000034901645,0.0008663568,0.000052998636,0.00008012498,0.00001171113,0.000022947217,0.0000595054,0.0002612765,0.97620744,0.022332016],"study_design_scores_gemma":[0.00015707848,0.000057523284,0.00023958439,0.0017587175,0.00016861192,0.0003246146,0.00003649491,0.000088675486,0.000079886784,0.0006634875,0.9964038,0.000021451242],"about_ca_topic_score_codex":0.0015291236,"about_ca_topic_score_gemma":0.0050596907,"teacher_disagreement_score":0.010422951,"about_ca_system_score_codex":0.0021076761,"about_ca_system_score_gemma":0.002883836,"threshold_uncertainty_score":0.03380257},"labels":[],"label_agreement":null},{"id":"W2549399469","doi":"10.1080/17474086.2017.1257935","title":"Controversies in the management of cancer-associated thrombosis","year":2016,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cancer; Intensive care medicine; Thrombosis; Pulmonary embolism; Complication; Low molecular weight heparin; Chemotherapy; Heparin; Surgery; Internal medicine","score_opus":0.04198261433712888,"score_gpt":0.4110703301228576,"score_spread":0.36908771578572874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549399469","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007381723,0.9861274,0.00010571008,0.011571017,0.0011045738,0.0000047347103,0.000017037637,0.000004330671,0.0009913762],"genre_scores_gemma":[0.0016640438,0.99002904,0.00022400229,0.0054520234,0.0023481476,0.000010122813,0.000024503202,0.000002690482,0.0002454625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784005,0.0008627308,0.00040071682,0.0002194445,0.0005788091,0.0000981834],"domain_scores_gemma":[0.9927475,0.004697322,0.00084965123,0.000092345916,0.0014201995,0.00019303747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003358198,0.00062670885,0.0014363664,0.002091767,0.0005965135,0.0021053224,0.0013981049,0.002981214,0.0044121635],"category_scores_gemma":[0.0138328215,0.00025839783,0.001075785,0.0018082089,0.0013037508,0.002476637,0.00091006,0.004053699,0.0014181654],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006524535,0.000038472266,0.00046381302,0.04062002,0.00023451587,0.00069443916,0.0004860895,0.00036919198,0.00024103068,0.01113585,0.18137467,0.76427674],"study_design_scores_gemma":[0.000035821937,0.00005054237,0.0007733289,0.06206988,0.00027843384,0.003300328,0.00047199128,0.00013246643,0.00012961435,0.009426246,0.9232941,0.000037229598],"about_ca_topic_score_codex":0.00248756,"about_ca_topic_score_gemma":0.0037606212,"teacher_disagreement_score":0.0044121635,"about_ca_system_score_codex":0.0013850168,"about_ca_system_score_gemma":0.0038858587,"threshold_uncertainty_score":0.017760098},"labels":[],"label_agreement":null},{"id":"W2555762447","doi":"10.1080/17474086.2017.1259559","title":"Baby hamster kidney cell–derived recombinant factor VIII: a quarter century of learning and clinical experience","year":2016,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bayer","keywords":"Medicine; Recombinant DNA; Quarter (Canadian coin); Baby hamster kidney cell; Hamster; Internal medicine; Immunology; Biochemistry; Gene; Biology","score_opus":0.05976342074246231,"score_gpt":0.4400422264527192,"score_spread":0.38027880571025685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555762447","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013518383,0.9962483,0.00012277304,0.0020875914,0.00051626517,0.0000052347873,0.000023265467,0.0000056937647,0.00085571164],"genre_scores_gemma":[0.0009378857,0.99659306,0.0002251065,0.0011996638,0.00057232985,0.000008174021,0.00003844205,0.0000029486027,0.00042231227],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989323,0.00032591884,0.000209762,0.00013050143,0.00035514994,0.000046444555],"domain_scores_gemma":[0.99592197,0.002569219,0.00040126883,0.000103429295,0.00085820054,0.00014580681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032699008,0.00049995683,0.001432641,0.0022063702,0.00028185072,0.0013143234,0.0007904491,0.0016554774,0.0053325724],"category_scores_gemma":[0.005526334,0.00028009078,0.00072039093,0.0029450788,0.0008508879,0.0024819956,0.0008778337,0.0021000388,0.0019249712],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010525242,0.000029546045,0.00027878786,0.053045962,0.00013157757,0.0003284908,0.00036050795,0.00017243832,0.0012818482,0.0051391153,0.05443264,0.88469386],"study_design_scores_gemma":[0.00001721366,0.00008776116,0.00074971834,0.021801796,0.000115732975,0.0014768126,0.00019397696,0.000035939218,0.00029236707,0.0018238019,0.97337884,0.000026119946],"about_ca_topic_score_codex":0.0017919,"about_ca_topic_score_gemma":0.0022266645,"teacher_disagreement_score":0.0053325724,"about_ca_system_score_codex":0.00094645185,"about_ca_system_score_gemma":0.0031275663,"threshold_uncertainty_score":0.017839193},"labels":[],"label_agreement":null},{"id":"W2565168385","doi":"10.1080/17474086.2017.1272410","title":"The current state of adverse event reporting in hemophilia","year":2016,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Adverse effect; Intensive care medicine; Current (fluid); Event (particle physics); Internal medicine","score_opus":0.07319955231219018,"score_gpt":0.46441864070533156,"score_spread":0.3912190883931414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565168385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007151398,0.99288106,0.00019128736,0.0049067335,0.0009976589,0.000012228907,0.00009264955,0.000014996279,0.0008319055],"genre_scores_gemma":[0.0014512531,0.99389666,0.00032862378,0.0022786453,0.001687623,0.000021280457,0.000103509854,0.000005845376,0.00022653739],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98725164,0.005095552,0.0025127192,0.0009024566,0.003937898,0.00029984373],"domain_scores_gemma":[0.93099445,0.044717465,0.011179925,0.001062612,0.011144668,0.00090091507],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015266849,0.0008364262,0.002483532,0.0041899243,0.00042277543,0.0026717873,0.003013933,0.0038440134,0.0057579638],"category_scores_gemma":[0.04418979,0.00048559048,0.0016765688,0.0057695336,0.0014974723,0.00330408,0.0012607661,0.0032123087,0.001933487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008459672,0.000017840488,0.00052848906,0.058792226,0.00021769301,0.00016071499,0.00022048272,0.00022392791,0.0001650269,0.0035186638,0.11619486,0.8198756],"study_design_scores_gemma":[0.000053268228,0.00009879023,0.0028243705,0.099228166,0.00048825695,0.0018998408,0.00030562805,0.00021073458,0.0002699424,0.0039238823,0.89063174,0.00006533609],"about_ca_topic_score_codex":0.0035294322,"about_ca_topic_score_gemma":0.00342882,"teacher_disagreement_score":0.98473316,"about_ca_system_score_codex":0.0021345762,"about_ca_system_score_gemma":0.0065414556,"threshold_uncertainty_score":0.080739796},"labels":[],"label_agreement":null},{"id":"W2769988410","doi":"10.1080/17474086.2018.1407241","title":"Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials","year":2017,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Randomized controlled trial; Venous thromboembolism; Duration (music); Incidence (geometry); Intensive care medicine; Pediatrics; Population; Clinical trial; Anticoagulant therapy; Surgery; Internal medicine; Thrombosis","score_opus":0.174496993218688,"score_gpt":0.4352950980767897,"score_spread":0.2607981048581017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769988410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009888409,0.99801767,0.00013596784,0.0010420211,0.00030041471,0.000045237175,0.000095270734,0.000005698483,0.00025885468],"genre_scores_gemma":[0.0020618103,0.99458486,0.0006546255,0.0017559088,0.0005702338,0.00015828134,0.00012761648,0.0000066338307,0.000080003745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9884375,0.0049112304,0.0036440268,0.00092879223,0.0018441476,0.0002342606],"domain_scores_gemma":[0.9079227,0.077828035,0.0072060656,0.0009226151,0.0056779613,0.00044266885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02092424,0.0012532932,0.0071851527,0.0034928753,0.00043752018,0.0030153883,0.0025815526,0.0027498351,0.007484062],"category_scores_gemma":[0.06880725,0.00060138584,0.0055249743,0.0044247094,0.00096912385,0.003103054,0.0010769541,0.0035909894,0.00082042644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015554535,0.000070766,0.00068453007,0.43135226,0.006048558,0.00007840339,0.0001503204,0.0003049141,0.00021695097,0.0024655554,0.021237478,0.5358348],"study_design_scores_gemma":[0.002183564,0.0007509588,0.0037408408,0.6612231,0.03764398,0.00058217405,0.00020931098,0.00039912993,0.00042220534,0.0054195696,0.2873224,0.000102694576],"about_ca_topic_score_codex":0.002400213,"about_ca_topic_score_gemma":0.0045841923,"teacher_disagreement_score":0.02092424,"about_ca_system_score_codex":0.0023628564,"about_ca_system_score_gemma":0.0057929256,"threshold_uncertainty_score":0.1106593},"labels":[],"label_agreement":null},{"id":"W2896637894","doi":"10.1080/17474086.2018.1537778","title":"Optimal frontline management of mantle cell lymphoma: can we agree?","year":2018,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mantle cell lymphoma; Mantle (geology); Intensive care medicine; Lymphoma; Oncology; Cancer research; Internal medicine; Geochemistry; Geology","score_opus":0.01045945692812617,"score_gpt":0.30996336456101303,"score_spread":0.29950390763288687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896637894","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000114848204,0.08177851,0.00038972695,0.11898924,0.7967255,0.000025200812,0.00006151299,0.00006560963,0.0018498672],"genre_scores_gemma":[0.0010249024,0.052306466,0.00039743667,0.061435662,0.88160944,0.000024733914,0.000050018138,0.000024743777,0.0031266497],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973459,0.00063860655,0.00060793414,0.0002773503,0.0009439182,0.00018634132],"domain_scores_gemma":[0.9855746,0.007131393,0.0009618158,0.00026218224,0.004908096,0.001161939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005643701,0.0015980136,0.0032670954,0.0015919957,0.0011361744,0.0036788497,0.0024094412,0.009496961,0.0046324637],"category_scores_gemma":[0.018787019,0.0005639505,0.00160286,0.000807057,0.0015325994,0.0043676808,0.0008849853,0.018285455,0.0033384536],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081889775,0.000025726435,0.00007130847,0.0009943997,0.000051077855,0.00016517282,0.000017351422,0.00004929365,0.000093890216,0.00068301643,0.9585818,0.03918508],"study_design_scores_gemma":[0.00018239813,0.000067886824,0.00039238186,0.0023557981,0.00017882913,0.0008380102,0.000059117763,0.00016800805,0.00014401853,0.0019173567,0.9936621,0.000034077675],"about_ca_topic_score_codex":0.0008944916,"about_ca_topic_score_gemma":0.0025737297,"teacher_disagreement_score":0.009496961,"about_ca_system_score_codex":0.0019585225,"about_ca_system_score_gemma":0.002575401,"threshold_uncertainty_score":0.029847085},"labels":[],"label_agreement":null},{"id":"W2907343172","doi":"10.1080/17474086.2018.1564032","title":"Switching patients in the age of long-acting recombinant products?","year":2019,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"CSL Behring","keywords":"Medicine; Dosing; Regimen; Intensive care medicine; Expert opinion; Surgery; Pharmacology","score_opus":0.09632214904559563,"score_gpt":0.4310467430819854,"score_spread":0.33472459403638977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907343172","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010327993,0.9969241,0.00006832971,0.0013672486,0.00051727943,0.000006691304,0.000027853031,0.0000059319614,0.0009792019],"genre_scores_gemma":[0.0010767778,0.99568355,0.000112956506,0.001720079,0.0006106989,0.000010667123,0.000055647124,0.0000020851346,0.00072755635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962056,0.000111869456,0.000057549223,0.00006380887,0.00011813392,0.000028056696],"domain_scores_gemma":[0.99941206,0.00032359024,0.00013506421,0.000009651365,0.00009010577,0.000029482946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007018011,0.0005030852,0.0010443133,0.00058485556,0.00015514441,0.00079723576,0.00068678276,0.0014036996,0.007641537],"category_scores_gemma":[0.0021713183,0.0001466311,0.0006810329,0.00064964994,0.000304467,0.001114537,0.0003892458,0.0017766419,0.0023627789],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013512131,0.000027871176,0.00014149064,0.029927615,0.00011553186,0.00015823443,0.00008772804,0.000102246675,0.000353336,0.0021673632,0.080856524,0.8859269],"study_design_scores_gemma":[0.000077446515,0.00012214168,0.00087715394,0.03339106,0.00028114035,0.0022588498,0.00012001214,0.000059279868,0.00021495858,0.0019658466,0.9606103,0.000021798072],"about_ca_topic_score_codex":0.0009975102,"about_ca_topic_score_gemma":0.0015907275,"teacher_disagreement_score":0.007641537,"about_ca_system_score_codex":0.00035643895,"about_ca_system_score_gemma":0.0007124755,"threshold_uncertainty_score":0.025563419},"labels":[],"label_agreement":null},{"id":"W2930354013","doi":"10.1080/17474086.2019.1602036","title":"Humanistic burden of patients with chronic graft-versus-host disease - systematic literature review of health-related quality of life and functional status","year":2019,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Quality of life (healthcare); Graft-versus-host disease; Hematopoietic stem cell transplantation; Disease; Intensive care medicine; MEDLINE; Cohort; Physical therapy; Internal medicine","score_opus":0.045753115184816555,"score_gpt":0.35933121948348495,"score_spread":0.3135781042986684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930354013","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003009063,0.99908364,0.000031059564,0.00017396314,0.000057114914,0.000024599703,0.00016439505,0.0000020409873,0.00016221906],"genre_scores_gemma":[0.0043712184,0.99499583,0.0001400041,0.00022547394,0.00005569966,0.00004509156,0.00011014806,0.0000012902689,0.000055185617],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.997303,0.00085735635,0.0009240435,0.00027539983,0.0005423671,0.000097836026],"domain_scores_gemma":[0.98780084,0.008774448,0.0021737937,0.00013365375,0.000980791,0.0001365839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035784962,0.00085646764,0.0037492728,0.00882407,0.00036028697,0.001550145,0.0009516439,0.0010984249,0.0050104177],"category_scores_gemma":[0.015381603,0.00039776595,0.0031767949,0.0076005515,0.00053268275,0.0011709984,0.0008843367,0.00073484384,0.00028064597],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012572705,0.00001580615,0.0013943473,0.87758845,0.0040531293,0.00010471442,0.00018174757,0.00009991548,0.00016213414,0.00040089834,0.004789498,0.11108371],"study_design_scores_gemma":[0.00009267317,0.00013567816,0.009969175,0.9039805,0.027065707,0.00081536686,0.0003045583,0.00008153233,0.00014189947,0.0005234035,0.056851868,0.00003757685],"about_ca_topic_score_codex":0.0068619605,"about_ca_topic_score_gemma":0.01766829,"teacher_disagreement_score":0.00882407,"about_ca_system_score_codex":0.0017000781,"about_ca_system_score_gemma":0.0066088187,"threshold_uncertainty_score":0.01892513},"labels":[],"label_agreement":null},{"id":"W2931542173","doi":"10.1080/17474086.2019.1605288","title":"A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease","year":2019,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Graft-versus-host disease; Disease; Incidence (geometry); Hematopoietic stem cell transplantation; Cohort; Transplantation; Internal medicine; Mortality rate; Intensive care medicine","score_opus":0.028515375590845115,"score_gpt":0.3590130971644008,"score_spread":0.33049772157355567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2931542173","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005891005,0.9981186,0.00007982708,0.00021541148,0.000100489866,0.00013280306,0.000515514,0.0000061637043,0.00024211535],"genre_scores_gemma":[0.0047108824,0.99409723,0.00027746876,0.00030144904,0.000066479304,0.00018764955,0.00026457603,0.00000278444,0.000091618414],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.995856,0.0010006248,0.0018428491,0.00039444538,0.0007590401,0.00014698326],"domain_scores_gemma":[0.98635197,0.008919482,0.0029057628,0.00015615083,0.0015143349,0.00015222057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004159227,0.0013248546,0.005702367,0.012947629,0.0005494459,0.0018042225,0.0016031503,0.0013876641,0.0055342643],"category_scores_gemma":[0.018680494,0.00061162416,0.005080712,0.0124934055,0.00058491883,0.0016447228,0.0010642811,0.00083137694,0.00040336463],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001161852,0.0000116370775,0.0009585805,0.9448495,0.0036402512,0.00012289557,0.00013119823,0.00007010424,0.00015245931,0.00018697654,0.0030282459,0.04673208],"study_design_scores_gemma":[0.00011191108,0.00013031528,0.005275093,0.92266065,0.03977286,0.00076520897,0.00021150566,0.00006415986,0.00014893846,0.00025734972,0.030569505,0.000032547738],"about_ca_topic_score_codex":0.0070185885,"about_ca_topic_score_gemma":0.018669637,"teacher_disagreement_score":0.012947629,"about_ca_system_score_codex":0.002627988,"about_ca_system_score_gemma":0.009037678,"threshold_uncertainty_score":0.021996379},"labels":[],"label_agreement":null},{"id":"W2955990262","doi":"10.1080/17474086.2019.1636645","title":"High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review","year":2019,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program; Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Heparin; Fondaparinux; Antibody; Platelet; Thrombosis; Immunology; Refractory (planetary science); Platelet activation; Platelet factor 4; Internal medicine; Venous thromboembolism","score_opus":0.09428233042341318,"score_gpt":0.4167660414438062,"score_spread":0.322483711020393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955990262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004501794,0.99939096,0.000033880107,0.00013231396,0.00012966731,0.0000036478705,0.000011855134,0.0000031678803,0.00024948898],"genre_scores_gemma":[0.00028347393,0.99924785,0.00006620174,0.00016035719,0.00010437996,0.000003819546,0.000016964113,5.154621e-7,0.000116322604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998103,0.000036871428,0.000039194147,0.000030727886,0.00006928547,0.000013702133],"domain_scores_gemma":[0.9994825,0.00027654815,0.00008863193,0.000009612326,0.000112789254,0.000029809376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005124398,0.00070038036,0.0014348543,0.0020314422,0.0001836919,0.0007842548,0.0009309243,0.00095404556,0.0037203971],"category_scores_gemma":[0.001074253,0.00020103062,0.00077657896,0.0020371103,0.0002699613,0.0007938505,0.00041882804,0.0014596442,0.0012052275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001070178,0.000067773275,0.00013143882,0.04915197,0.00029075198,0.000110849374,0.000038785973,0.00022874639,0.00077473733,0.001159228,0.03674055,0.9111982],"study_design_scores_gemma":[0.000121534445,0.0002605674,0.0014995591,0.028924244,0.0011758788,0.0016908094,0.00007202017,0.0001391219,0.00032322208,0.0014074246,0.9643489,0.000036808695],"about_ca_topic_score_codex":0.0011954119,"about_ca_topic_score_gemma":0.0022300335,"teacher_disagreement_score":0.0037203971,"about_ca_system_score_codex":0.00044949984,"about_ca_system_score_gemma":0.0009993503,"threshold_uncertainty_score":0.012445986},"labels":[],"label_agreement":null},{"id":"W2968803688","doi":"10.1080/17474086.2019.1657824","title":"Platelet and red cell transfusions for neonates: lifesavers or Trojan horses?","year":2019,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Platelet; Red Cell; Platelet transfusion; Intensive care medicine; Internal medicine","score_opus":0.05839979609643514,"score_gpt":0.38351045092977504,"score_spread":0.3251106548333399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968803688","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019905783,0.99917537,0.000028445085,0.00038785682,0.0002255181,0.0000011639527,0.000005766379,0.0000016984291,0.00015421811],"genre_scores_gemma":[0.00024379267,0.99838734,0.00008218095,0.0006289379,0.0005127372,0.0000027168264,0.000012237739,8.984708e-7,0.00012920421],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9994185,0.00013976177,0.00012269232,0.000098007564,0.00018023376,0.000040752628],"domain_scores_gemma":[0.99857545,0.0008489508,0.00026476433,0.000021637594,0.00021899615,0.00007014085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012595424,0.0009755664,0.0024290022,0.0018803773,0.00026252275,0.0016586714,0.0014592139,0.0021212122,0.0050689727],"category_scores_gemma":[0.0033556789,0.00030185358,0.0009770762,0.0020531544,0.0007393855,0.0017383768,0.0007802611,0.0032349203,0.0015668344],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013593226,0.00004676385,0.00019988448,0.035108317,0.00030538157,0.00019327094,0.000049409387,0.00019975605,0.00032444947,0.0029276677,0.07075409,0.88975513],"study_design_scores_gemma":[0.0001456581,0.0001509353,0.00094721036,0.040184386,0.0008659669,0.0020097778,0.00012753665,0.00014537596,0.00017185582,0.0030413147,0.9521651,0.00004476198],"about_ca_topic_score_codex":0.0014638675,"about_ca_topic_score_gemma":0.0030666413,"teacher_disagreement_score":0.0050689727,"about_ca_system_score_codex":0.000636728,"about_ca_system_score_gemma":0.0016430512,"threshold_uncertainty_score":0.016957462},"labels":[],"label_agreement":null},{"id":"W3082023690","doi":"10.1080/17474086.2020.1818065","title":"Patient-reported symptom burden of chronic graft versus host disease: a systematic literature review","year":2020,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Quality of life (healthcare); MEDLINE; Graft-versus-host disease; Systematic review; Intensive care medicine; Hematopoietic stem cell transplantation; Generalizability theory; Disease; Randomized controlled trial; Clinical trial; Transplantation; Internal medicine","score_opus":0.02380648728980961,"score_gpt":0.3477728820044329,"score_spread":0.3239663947146233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082023690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00097655907,0.997825,0.000083384984,0.00025870945,0.00007141532,0.00017618963,0.00039138726,0.000005610102,0.0002117266],"genre_scores_gemma":[0.013372304,0.98503035,0.00040082418,0.00045636596,0.000061009046,0.0003447914,0.00024378428,0.0000032762239,0.000087383756],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99434423,0.0019642552,0.001998106,0.00047911363,0.0010348939,0.00017933475],"domain_scores_gemma":[0.97639674,0.016977733,0.0042192764,0.000224131,0.0019377117,0.00024446804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006394925,0.0013000229,0.006601241,0.009853326,0.0005184873,0.002130269,0.0014669431,0.0016670258,0.004776523],"category_scores_gemma":[0.029064506,0.00073227653,0.0051839086,0.011081128,0.00070987304,0.0018143221,0.0012381509,0.0010017181,0.00030072784],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000998859,0.000011870837,0.0009315177,0.9643449,0.005592604,0.00008404349,0.00013870707,0.00006991124,0.00008684936,0.00013483626,0.0015292639,0.026975652],"study_design_scores_gemma":[0.00015493228,0.00014648326,0.006304013,0.9272347,0.050357405,0.00047290832,0.00031750032,0.000077155186,0.00010728857,0.00025089947,0.014542388,0.00003440614],"about_ca_topic_score_codex":0.007188096,"about_ca_topic_score_gemma":0.022425024,"teacher_disagreement_score":0.009853326,"about_ca_system_score_codex":0.0029665018,"about_ca_system_score_gemma":0.009842566,"threshold_uncertainty_score":0.033819973},"labels":[],"label_agreement":null},{"id":"W3109921710","doi":"10.1080/17474086.2021.1860002","title":"Evidence-based indications of platelet-rich plasma therapy","year":2020,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Periodontal Regeneration and Treatments","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University","funders":"","keywords":"Medicine; Intensive care medicine; Platelet; Internal medicine","score_opus":0.1263385500403964,"score_gpt":0.4214560583552552,"score_spread":0.2951175083148588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109921710","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012632077,0.9966425,0.00014612994,0.0005826637,0.0002808365,0.00006406138,0.00013952609,0.0000067858327,0.0020112453],"genre_scores_gemma":[0.0028519542,0.9949715,0.00060483464,0.00063726335,0.00019974043,0.00008644295,0.00020529897,0.000002888836,0.00043998793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987237,0.00035636182,0.00038759407,0.000113290596,0.00037471476,0.000044311153],"domain_scores_gemma":[0.9976178,0.0013605907,0.0005342233,0.000035052417,0.00039922935,0.00005311724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001320484,0.0009467788,0.0020573607,0.0034525783,0.00030276956,0.0015749241,0.0013830371,0.0016603486,0.013799381],"category_scores_gemma":[0.0056021516,0.00026234286,0.002032923,0.0024324039,0.00042514835,0.0009222641,0.00065771065,0.0014941045,0.002091988],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030029513,0.000059698297,0.00028648842,0.36317652,0.0010627767,0.00026417707,0.00008150084,0.0002728191,0.0007357719,0.0032115784,0.02355433,0.60699403],"study_design_scores_gemma":[0.0002907088,0.00022244545,0.0023796642,0.4538881,0.004996267,0.0018692572,0.00012873001,0.00020978163,0.0007178367,0.0040420587,0.53121454,0.00004073716],"about_ca_topic_score_codex":0.0012883241,"about_ca_topic_score_gemma":0.0021901233,"teacher_disagreement_score":0.013799381,"about_ca_system_score_codex":0.0010747429,"about_ca_system_score_gemma":0.0028485009,"threshold_uncertainty_score":0.0461635},"labels":[],"label_agreement":null},{"id":"W3125119901","doi":"10.1080/17474086.2021.1875817","title":"Key questions in the new hemophilia era: update on concomitant use of FVIII and emicizumab in hemophilia A patients with inhibitors","year":2021,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Bispecific antibody; Concomitant; Expert opinion; Immunology; Monoclonal antibody; Intensive care medicine; Antibody; Internal medicine","score_opus":0.03813247909115668,"score_gpt":0.36375848524961635,"score_spread":0.32562600615845966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125119901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034809284,0.99883395,0.000031493728,0.0005426879,0.00024415192,0.0000029992473,0.0000160942,0.0000030689437,0.00029086534],"genre_scores_gemma":[0.000321846,0.99858654,0.00007758744,0.0004895451,0.00029770914,0.0000047145254,0.000029548066,0.0000011827028,0.00019139818],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995561,0.00012091363,0.00009018867,0.000062432075,0.00014278528,0.000027562259],"domain_scores_gemma":[0.99873656,0.00071624847,0.00021385013,0.000017085453,0.0002675634,0.000048747876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010300041,0.00071035075,0.0018451745,0.0020456198,0.0002348085,0.0011074925,0.0009749087,0.0015555901,0.006708431],"category_scores_gemma":[0.002417771,0.00025218984,0.0011600167,0.0020726486,0.00035456155,0.0015777309,0.00057286944,0.0019569108,0.0014483588],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111188354,0.00004151898,0.00017350199,0.061631158,0.00025301104,0.00017164768,0.00008106137,0.00019570968,0.0004143777,0.0019155415,0.079606056,0.8554052],"study_design_scores_gemma":[0.000056353056,0.00010052746,0.0009589013,0.04310411,0.0007039189,0.0014885764,0.00009304055,0.000087921,0.00012085969,0.0014918979,0.95177233,0.000021630709],"about_ca_topic_score_codex":0.0014952446,"about_ca_topic_score_gemma":0.0028155793,"teacher_disagreement_score":0.006708431,"about_ca_system_score_codex":0.0007052775,"about_ca_system_score_gemma":0.0014056856,"threshold_uncertainty_score":0.022441983},"labels":[],"label_agreement":null},{"id":"W4324308734","doi":"10.1080/17474086.2023.2175661","title":"Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders","year":2023,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Blueprint; Psychosocial; Multidisciplinary approach; Distress; Intensive care medicine; Psychiatry","score_opus":0.2303191520935952,"score_gpt":0.5041977961139616,"score_spread":0.27387864402036644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324308734","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008896002,0.033022366,0.008370952,0.91921026,0.03176277,0.00038558207,0.0003530359,0.00032420256,0.005681183],"genre_scores_gemma":[0.04027877,0.078947626,0.19077428,0.6441854,0.026526997,0.0035552264,0.0027774705,0.00052101316,0.012433261],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.90705657,0.053772744,0.007120742,0.0056956704,0.018444097,0.007910152],"domain_scores_gemma":[0.61296105,0.14880407,0.014287813,0.02461174,0.10265762,0.09667774],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.15796427,0.0018476247,0.003453773,0.0054763653,0.0071865716,0.018524328,0.008389921,0.031278424,0.019590324],"category_scores_gemma":[0.19341311,0.0014905247,0.0034662867,0.0030760353,0.009320385,0.017188812,0.033570085,0.041155465,0.008333863],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015255967,0.0006134275,0.0020397587,0.003889821,0.0003266441,0.0004947018,0.0017590763,0.00079289783,0.001259509,0.066352054,0.7025819,0.21973765],"study_design_scores_gemma":[0.00028597302,0.0004225924,0.0022600356,0.016152978,0.00028633297,0.00033137389,0.0026555548,0.0008270028,0.0007506558,0.0768631,0.89898276,0.00018155514],"about_ca_topic_score_codex":0.00789231,"about_ca_topic_score_gemma":0.009781543,"teacher_disagreement_score":0.8420357,"about_ca_system_score_codex":0.013343341,"about_ca_system_score_gemma":0.19196779,"threshold_uncertainty_score":0.83540493},"labels":[],"label_agreement":null},{"id":"W4324311216","doi":"10.1080/17474086.2023.2181781","title":"Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding","year":2023,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"National Hemophilia Foundation","keywords":"Blueprint; Medicine; Workforce; Multidisciplinary approach; Summit; Capacity building; Workforce development; Medical education; Public relations; Nursing; Political science; Engineering","score_opus":0.26615155739254037,"score_gpt":0.5173313830945768,"score_spread":0.25117982570203645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324311216","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022130627,0.01425749,0.01905321,0.9302028,0.019068243,0.0010373286,0.0003889489,0.0005990449,0.013179874],"genre_scores_gemma":[0.096195094,0.038418345,0.2758643,0.53175616,0.019425038,0.008497653,0.0027929079,0.00092042814,0.026129974],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8439166,0.09321484,0.008122958,0.008569831,0.025916351,0.020259393],"domain_scores_gemma":[0.5739785,0.15587811,0.018020393,0.034226984,0.07266386,0.14523228],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21639809,0.0019075866,0.0023771634,0.00579882,0.009486941,0.019319728,0.010156322,0.027279135,0.024254221],"category_scores_gemma":[0.24577588,0.0019835162,0.0032245114,0.0028324395,0.012740437,0.020552885,0.05534981,0.033483375,0.008303672],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022286235,0.0007507551,0.0045263655,0.0035827456,0.00033216336,0.0009182163,0.0040790336,0.0013731068,0.0020108193,0.102701865,0.6142566,0.26524544],"study_design_scores_gemma":[0.00039346053,0.0006099252,0.0049659587,0.009655758,0.00015567492,0.00039016674,0.004949516,0.00087057054,0.00093943905,0.0761042,0.90074295,0.0002224038],"about_ca_topic_score_codex":0.013359295,"about_ca_topic_score_gemma":0.016913842,"teacher_disagreement_score":0.7836019,"about_ca_system_score_codex":0.015336389,"about_ca_system_score_gemma":0.2817644,"threshold_uncertainty_score":0.96632063},"labels":[],"label_agreement":null},{"id":"W4324311538","doi":"10.1080/17474086.2023.2183836","title":"Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementation science","year":2023,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institutes of Health; Health Resources and Services Administration; National Hemophilia Foundation","keywords":"Blueprint; Medicine; Inclusion (mineral); Stakeholder; Health care; Equity (law); Public relations; Workforce; Nursing; Health services research; Diversity (politics); Health equity; Public health; Political science; Sociology","score_opus":0.2813170922981152,"score_gpt":0.5870100944442785,"score_spread":0.30569300214616335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324311538","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011330668,0.07827797,0.012038525,0.87913114,0.019176124,0.0012927103,0.00036402114,0.00025696124,0.008329428],"genre_scores_gemma":[0.07229696,0.16708884,0.27427152,0.45214495,0.012048288,0.012082417,0.0017634762,0.00048025523,0.007823322],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.7557707,0.18660419,0.01348973,0.0073531377,0.027468193,0.009314036],"domain_scores_gemma":[0.46874976,0.35906947,0.015326414,0.029234882,0.08211211,0.04550732],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.27299058,0.0017376521,0.004718703,0.006451225,0.007629108,0.019135874,0.007732688,0.025590189,0.016498571],"category_scores_gemma":[0.3165253,0.0016855026,0.0054680374,0.004635028,0.0127122,0.020633198,0.027777899,0.03051987,0.004206404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001281168,0.00073392835,0.0023761303,0.026578717,0.00071858754,0.00043455668,0.007159116,0.0011517281,0.00092743494,0.1673346,0.40484425,0.38761282],"study_design_scores_gemma":[0.00032738177,0.0005721413,0.003868436,0.110337205,0.0005728008,0.00030632375,0.008893721,0.0010144953,0.000632029,0.12031778,0.7529509,0.00020684388],"about_ca_topic_score_codex":0.018124368,"about_ca_topic_score_gemma":0.020607598,"teacher_disagreement_score":0.7270094,"about_ca_system_score_codex":0.022405546,"about_ca_system_score_gemma":0.2719184,"threshold_uncertainty_score":0.89653206},"labels":[],"label_agreement":null},{"id":"W4327892775","doi":"10.1080/17474086.2023.2192474","title":"Applications of artificial intelligence in clinical management, research, and health administration: imaging perspectives with a focus on hemophilia","year":2023,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Health care; Workforce; Intervention (counseling); Medical physics; Nursing","score_opus":0.14198181882217722,"score_gpt":0.5248402677431172,"score_spread":0.38285844892094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327892775","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00087159727,0.9064588,0.0050895317,0.07071002,0.0034796442,0.00002207729,0.00002791401,0.00004326755,0.013297104],"genre_scores_gemma":[0.01808854,0.9436218,0.0060766325,0.020724127,0.0077521,0.000038406026,0.00003056662,0.000021326732,0.003646506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99775666,0.0012230488,0.00014913615,0.00018386164,0.0005874372,0.00009983646],"domain_scores_gemma":[0.9913667,0.0064415117,0.00050006574,0.00014271104,0.0012757654,0.00027329155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038410255,0.0005048138,0.00056343037,0.0026978191,0.0004853843,0.0029450704,0.0006593519,0.0029779547,0.0026152718],"category_scores_gemma":[0.006653824,0.00017105894,0.0004995876,0.0020855207,0.0027196761,0.0023991608,0.0012096674,0.003952658,0.0008730902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053881486,0.00006509912,0.00144024,0.0062589217,0.00010763484,0.00052502553,0.0011084812,0.0012690675,0.0011753013,0.13135901,0.12543447,0.73120296],"study_design_scores_gemma":[0.000010311752,0.00013016375,0.003067323,0.009706124,0.00005416261,0.0025752708,0.0011326622,0.0008168832,0.000528952,0.057335753,0.92459226,0.000050235554],"about_ca_topic_score_codex":0.0015564878,"about_ca_topic_score_gemma":0.002777802,"teacher_disagreement_score":0.0038410255,"about_ca_system_score_codex":0.0018858534,"about_ca_system_score_gemma":0.0025492036,"threshold_uncertainty_score":0.020313561},"labels":[],"label_agreement":null},{"id":"W4377564037","doi":"10.1080/17474086.2023.2216930","title":"Strategies to overcome the diagnostic challenges of autoimmune hemolytic anemias","year":2023,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministero della Salute","keywords":"Medicine; Autoimmune hemolytic anemia; Lymphoproliferative disorders; Immunology; Hematologic disorders; Diagnostic test; Intensive care medicine; Pediatrics; Antibody; Lymphoma","score_opus":0.06736388104555191,"score_gpt":0.3964508081188775,"score_spread":0.3290869270733256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377564037","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007242698,0.99630535,0.0002767913,0.0018050676,0.00051727943,0.00000633111,0.000019886464,0.000012689838,0.0009842078],"genre_scores_gemma":[0.001049939,0.99562836,0.00061703427,0.0014315663,0.0007033274,0.000012915676,0.0000631077,0.0000034656875,0.00049017894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952495,0.00015411091,0.00006893416,0.00006920146,0.00014525783,0.00003753834],"domain_scores_gemma":[0.998662,0.00067943655,0.00016616585,0.000035527108,0.00039306798,0.000063753876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014653438,0.0007951913,0.0010640626,0.0022324964,0.0002241463,0.001144958,0.0010721377,0.0015437492,0.0056699165],"category_scores_gemma":[0.0033547685,0.00016881074,0.0007284311,0.0011415308,0.00041382527,0.001457163,0.0007546627,0.002309082,0.0024197625],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005359977,0.000045175708,0.000236917,0.018924523,0.0001460369,0.00025343345,0.000066831366,0.00025353738,0.00058259926,0.0058360393,0.06783305,0.9057683],"study_design_scores_gemma":[0.00002234665,0.000058570757,0.0005499625,0.01102857,0.00019780097,0.0015833308,0.00008098744,0.00010453512,0.00026792398,0.0032501228,0.9828403,0.000015485582],"about_ca_topic_score_codex":0.0010038539,"about_ca_topic_score_gemma":0.0015435603,"teacher_disagreement_score":0.0056699165,"about_ca_system_score_codex":0.00059260573,"about_ca_system_score_gemma":0.0015863373,"threshold_uncertainty_score":0.018967748},"labels":[],"label_agreement":null},{"id":"W4379509220","doi":"10.1080/17474086.2023.2221846","title":"Gastrointestinal bleeding in von Willebrand patients: special diagnostic and management considerations","year":2023,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Queen's University","funders":"","keywords":"Angiodysplasia; Medicine; Von Willebrand disease; Von Willebrand factor; Gastrointestinal bleeding; Intensive care medicine; Internal medicine; Platelet","score_opus":0.034934350646900494,"score_gpt":0.35381197757566213,"score_spread":0.31887762692876165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379509220","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017329722,0.99654526,0.00012557123,0.0016065984,0.00044293804,0.000005055475,0.000018181208,0.0000065275317,0.0010765479],"genre_scores_gemma":[0.0016633205,0.9951982,0.00036737075,0.0012166961,0.0009218659,0.0000074877616,0.00004888598,0.0000017383627,0.00057451],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979824,0.00005530357,0.00003450204,0.000026172183,0.00006747267,0.000018410148],"domain_scores_gemma":[0.99962544,0.00019488644,0.00006273573,0.000006435808,0.000086847875,0.000023614284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004580205,0.0005083462,0.0009990808,0.0010094615,0.00022046568,0.00079003087,0.0004520822,0.0011640226,0.003574406],"category_scores_gemma":[0.0010868172,0.00012208981,0.0005241955,0.0008980976,0.00028950375,0.00091112056,0.0003811627,0.001523193,0.0010098745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009591524,0.000039191935,0.0004490253,0.02165575,0.000120695724,0.0011075477,0.000119137454,0.00020778237,0.0009533447,0.0026695044,0.08059843,0.8919837],"study_design_scores_gemma":[0.000048469617,0.000094168114,0.002299694,0.017486537,0.00030025878,0.013357275,0.00021100232,0.0001535448,0.00029945807,0.0036907974,0.96203077,0.000027974667],"about_ca_topic_score_codex":0.0009817984,"about_ca_topic_score_gemma":0.0017078755,"teacher_disagreement_score":0.003574406,"about_ca_system_score_codex":0.00033871035,"about_ca_system_score_gemma":0.0009434458,"threshold_uncertainty_score":0.011957586},"labels":[],"label_agreement":null},{"id":"W4385827620","doi":"10.1080/17474086.2023.2243386","title":"Patient-centered care in von Willebrand disease: are we there yet?","year":2023,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; St. Michael's Hospital","funders":"","keywords":"Medicine; Intensive care medicine; Disease; Von Willebrand disease; Pediatrics; Von Willebrand factor; Internal medicine; Platelet","score_opus":0.018628209518339694,"score_gpt":0.32024152614963536,"score_spread":0.30161331663129565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385827620","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007034174,0.78202194,0.0013459626,0.20591626,0.004013247,0.00003722435,0.000048829985,0.000046770194,0.0058663944],"genre_scores_gemma":[0.020056667,0.9116229,0.0035324115,0.055858362,0.0069777225,0.00013313837,0.0000949224,0.000020562109,0.0017032824],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99403185,0.003795659,0.00027923702,0.00036260905,0.0011570487,0.00037371652],"domain_scores_gemma":[0.9828372,0.0119195515,0.0012481216,0.000263066,0.0022238465,0.0015081409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006740158,0.0005230565,0.0011041953,0.0006921323,0.0009876922,0.0036747048,0.0014704088,0.004373873,0.007444288],"category_scores_gemma":[0.019553507,0.0002034324,0.0010590991,0.00088952214,0.0018919549,0.0032482105,0.0026426443,0.0066919983,0.0011066478],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008728938,0.00009095143,0.0008548583,0.015437515,0.00024110891,0.0002457952,0.0014693101,0.0003912893,0.00020899574,0.033942055,0.20752673,0.73950404],"study_design_scores_gemma":[0.000097863056,0.00015151965,0.0021372149,0.052293155,0.00024704312,0.0010466838,0.0020832235,0.0003088991,0.00018814551,0.03149969,0.90988785,0.000058809994],"about_ca_topic_score_codex":0.0023729333,"about_ca_topic_score_gemma":0.0038462563,"teacher_disagreement_score":0.007444288,"about_ca_system_score_codex":0.0029138487,"about_ca_system_score_gemma":0.0061963336,"threshold_uncertainty_score":0.035645783},"labels":[],"label_agreement":null},{"id":"W4387540453","doi":"10.1080/17474086.2023.2268273","title":"Immunotherapy for myelodysplastic syndrome and acute myeloid leukemia: where do we stand?","year":2023,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Chimeric antigen receptor; Immunotherapy; Myeloid leukemia; Clinical trial; Immunology; Myelodysplastic syndromes; Myeloid; Tolerability; T cell; Immune system; Oncology; Cancer research; Internal medicine; Bone marrow; Adverse effect","score_opus":0.049156869697557774,"score_gpt":0.40672588013009886,"score_spread":0.3575690104325411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387540453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004837978,0.99790466,0.00004934429,0.00095080736,0.0005124527,0.0000031373559,0.000011980513,0.0000054171855,0.0005138813],"genre_scores_gemma":[0.000386998,0.9974607,0.00009427119,0.0009102384,0.00053465145,0.0000058490477,0.000024856972,0.0000014741889,0.0005809309],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979097,0.00005296987,0.000023458142,0.000029567009,0.00008295578,0.000020138503],"domain_scores_gemma":[0.99963355,0.000158102,0.00005572756,0.000007715464,0.00011389561,0.00003097951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006627085,0.00057846814,0.0011507395,0.0009849089,0.00018786907,0.0008196946,0.0007234263,0.0012081761,0.003917729],"category_scores_gemma":[0.0009095359,0.00014553928,0.00050846057,0.0011237196,0.0002989501,0.0011490844,0.00044193908,0.0019911542,0.0021440051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008672138,0.000033479122,0.0000778439,0.014036565,0.00009115353,0.000091300644,0.000034635646,0.00021526702,0.00074100407,0.0021733292,0.08664247,0.8957763],"study_design_scores_gemma":[0.00004020913,0.000091425565,0.0004149316,0.0071267695,0.00011864295,0.00064860337,0.000041216197,0.000065781,0.00013408336,0.0017150006,0.9895914,0.000012085929],"about_ca_topic_score_codex":0.0008753564,"about_ca_topic_score_gemma":0.0017072164,"teacher_disagreement_score":0.003917729,"about_ca_system_score_codex":0.00048230763,"about_ca_system_score_gemma":0.0009151947,"threshold_uncertainty_score":0.013106108},"labels":[],"label_agreement":null},{"id":"W4390273452","doi":"10.1080/17474086.2023.2298333","title":"Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P’s) for anti-PF4 diseases","year":2023,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Public Health Agency of Canada; Heart and Stroke Foundation of Canada","keywords":"Medicine; Hematology; Immune system; Immunology; Thrombosis; Platelet; Immune thrombocytopenia; Coronavirus disease 2019 (COVID-19); Antibody; Internal medicine; Disease; Infectious disease (medical specialty)","score_opus":0.03911822036750513,"score_gpt":0.36685744330676123,"score_spread":0.3277392229392561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390273452","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002049351,0.9525626,0.0005760522,0.037367485,0.007707773,0.000010222538,0.000026193691,0.00002498197,0.0015197078],"genre_scores_gemma":[0.0031854226,0.94920033,0.00087779295,0.01973224,0.025773808,0.00002848247,0.000047443238,0.000012922984,0.0011414939],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99910825,0.00034760966,0.000115426454,0.000114993774,0.00023420148,0.00007958348],"domain_scores_gemma":[0.9960846,0.0022111305,0.00033204013,0.00006987667,0.0010101318,0.00029221232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029519997,0.000915363,0.0015412339,0.0019079809,0.0005075439,0.0020014266,0.001303011,0.004003697,0.0038002243],"category_scores_gemma":[0.004043745,0.0002504937,0.00095852016,0.0011255308,0.0023135804,0.003840628,0.0012727943,0.0072338725,0.0015714661],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001796718,0.00006861022,0.0007502986,0.012142198,0.00016458062,0.0009856096,0.00040840282,0.00053533335,0.0013793078,0.042653084,0.3206759,0.62005705],"study_design_scores_gemma":[0.00004094767,0.00015630761,0.0010442339,0.009739351,0.00010276784,0.003394926,0.00039259018,0.00030878538,0.0001976262,0.022382678,0.9621931,0.000046662983],"about_ca_topic_score_codex":0.0013532045,"about_ca_topic_score_gemma":0.0020886569,"teacher_disagreement_score":0.004003697,"about_ca_system_score_codex":0.0016797163,"about_ca_system_score_gemma":0.0023825476,"threshold_uncertainty_score":0.015611827},"labels":[],"label_agreement":null},{"id":"W4396773874","doi":"10.1080/17474086.2024.2353761","title":"How clinicians and persons with hemophilia may approach shared decision-making","year":2024,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"","keywords":"Medicine; Intensive care medicine; Clinical decision making","score_opus":0.02905904599143895,"score_gpt":0.3868677625577894,"score_spread":0.35780871656635044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396773874","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002272432,0.014997265,0.0002102473,0.10545884,0.8782545,0.000020338812,0.000029225812,0.000033852873,0.00097307615],"genre_scores_gemma":[0.0004040999,0.011759114,0.00022292447,0.044002075,0.94100606,0.00003344143,0.000020626434,0.000026945516,0.0025247682],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9826015,0.0073580286,0.0021204967,0.0010374039,0.0060794465,0.0008031028],"domain_scores_gemma":[0.88194615,0.07493993,0.004552132,0.0019989938,0.027312804,0.009250043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028534817,0.0034967777,0.004717084,0.0032962316,0.0034586329,0.012548966,0.004750869,0.02883168,0.01051333],"category_scores_gemma":[0.09075189,0.0016266606,0.003263389,0.0014869714,0.0044079027,0.0065695937,0.002537004,0.03800687,0.0072310893],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026405614,0.000009407008,0.000026828939,0.00035767778,0.000042410276,0.00005581397,0.000038396247,0.000019166191,0.000019059305,0.00057728024,0.9933193,0.005508297],"study_design_scores_gemma":[0.00019795657,0.000043648324,0.00024376235,0.0021208273,0.00021487716,0.00024706702,0.00013796064,0.00018885419,0.000062128136,0.0028330334,0.9936707,0.00003900454],"about_ca_topic_score_codex":0.0032631457,"about_ca_topic_score_gemma":0.011575753,"teacher_disagreement_score":0.02883168,"about_ca_system_score_codex":0.0055924435,"about_ca_system_score_gemma":0.008579079,"threshold_uncertainty_score":0.15090835},"labels":[],"label_agreement":null},{"id":"W4396774129","doi":"10.1080/17474086.2024.2353772","title":"Advances in our understanding of genetic markers and targeted therapies for pediatric LCH","year":2024,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Langerhans cell histiocytosis; Medicine; Histiocytosis; Myeloid; Targeted therapy; Pathology; Immunology; Disease; Internal medicine; Cancer","score_opus":0.021521335484386287,"score_gpt":0.3501035856866171,"score_spread":0.3285822502022308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396774129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006486405,0.98473084,0.0018214313,0.008584671,0.0010745308,0.000010075662,0.000057874095,0.00003703938,0.0030348115],"genre_scores_gemma":[0.007847567,0.97972494,0.0030121088,0.004648164,0.0034294399,0.000026178705,0.00012771612,0.000016634927,0.0011672834],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994578,0.00014743554,0.00006192212,0.00010732988,0.00017960511,0.0000459952],"domain_scores_gemma":[0.9975746,0.0014206144,0.00023745355,0.00006223224,0.0005785735,0.00012646145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016941201,0.0006004777,0.0010574562,0.0011317084,0.00021889163,0.0012338426,0.0007857315,0.0014602231,0.0039167427],"category_scores_gemma":[0.0029944086,0.0002058778,0.00084193685,0.0006091598,0.00061987323,0.0016895175,0.0006034692,0.0038482484,0.0015562248],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011295702,0.000063332336,0.0015417236,0.00442984,0.00012103298,0.0007223787,0.00009168718,0.0007255156,0.0029663432,0.01128131,0.05561085,0.92233306],"study_design_scores_gemma":[0.00004137844,0.00014152298,0.00213127,0.0040665953,0.00019213084,0.0041862326,0.00010211546,0.00058066094,0.0012963027,0.009454158,0.97777367,0.00003391589],"about_ca_topic_score_codex":0.0012527043,"about_ca_topic_score_gemma":0.002084358,"teacher_disagreement_score":0.0039167427,"about_ca_system_score_codex":0.0010262493,"about_ca_system_score_gemma":0.0011601107,"threshold_uncertainty_score":0.013102829},"labels":[],"label_agreement":null},{"id":"W4396921310","doi":"10.1080/17474086.2024.2356258","title":"The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Medicine; Myeloid leukemia; Myeloid; Leukemia; Cancer research; Oncology; Immunology","score_opus":0.010201312912358627,"score_gpt":0.3202986969299171,"score_spread":0.31009738401755843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396921310","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008566591,0.9706452,0.0011263604,0.007910528,0.0013289603,0.000044818455,0.00022922082,0.00005621569,0.0100921],"genre_scores_gemma":[0.1302759,0.8478517,0.0025663292,0.008742586,0.0037676645,0.0001172545,0.00079700974,0.000029443318,0.0058521647],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9997743,0.000092587085,0.000019522231,0.000030232353,0.000058776714,0.000024660976],"domain_scores_gemma":[0.9997446,0.00010001277,0.00006726538,0.000007229689,0.000053521595,0.00002743985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047282875,0.00021925948,0.0006664428,0.00031987106,0.00013266911,0.000623975,0.0003759841,0.00049765257,0.004797095],"category_scores_gemma":[0.0009625656,0.000056969813,0.00059905206,0.00023780232,0.00013003257,0.00055427756,0.00034885277,0.0012793635,0.0010151834],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000831232,0.000103566155,0.00060199376,0.0039169523,0.0002722717,0.00028792638,0.0000574562,0.0005035072,0.0031292797,0.0036868553,0.040285114,0.94632393],"study_design_scores_gemma":[0.0012334852,0.0022208376,0.0053459825,0.004883106,0.00094140676,0.0036382282,0.0001279624,0.00089298293,0.0023972963,0.009019188,0.969257,0.000042532294],"about_ca_topic_score_codex":0.0002550412,"about_ca_topic_score_gemma":0.0013269363,"teacher_disagreement_score":0.004797095,"about_ca_system_score_codex":0.00039781505,"about_ca_system_score_gemma":0.0004092094,"threshold_uncertainty_score":0.016047895},"labels":[],"label_agreement":null},{"id":"W4399687038","doi":"10.1080/17474086.2024.2366540","title":"The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease","year":2024,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Medicine; Cold agglutinin disease; Algorithm; Disease management; Intensive care medicine; Disease; Immunology; Internal medicine; Parkinson's disease; Antibody; Computer science","score_opus":0.00941058982169735,"score_gpt":0.28811738173345014,"score_spread":0.2787067919117528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399687038","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047711402,0.40257174,0.0791812,0.30984947,0.008557212,0.0030640615,0.0046606725,0.0018306243,0.14257355],"genre_scores_gemma":[0.28955066,0.40754247,0.18953165,0.056417003,0.010178982,0.0029592293,0.0091179125,0.0002244433,0.034477714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995852,0.00012177199,0.000101395985,0.00006431514,0.000073919044,0.000053424286],"domain_scores_gemma":[0.9996111,0.000089084104,0.000069632384,0.000006746746,0.00014041882,0.000083130995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056998205,0.0006627934,0.00080863055,0.0017868596,0.0008123469,0.0012496023,0.0009970673,0.0015531619,0.007962819],"category_scores_gemma":[0.0019869683,0.00015403476,0.0009677357,0.00075449585,0.0002476861,0.001662769,0.001066885,0.0019950354,0.0023050834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022490573,0.00024352061,0.02246577,0.003807927,0.00016258973,0.01887791,0.0007393561,0.0019417704,0.0010146871,0.009086178,0.27406278,0.66737264],"study_design_scores_gemma":[0.00039025903,0.0004691031,0.04440271,0.03367565,0.00080301706,0.14452955,0.0041442625,0.007647907,0.0014364765,0.044815015,0.71743363,0.00025240224],"about_ca_topic_score_codex":0.0016443594,"about_ca_topic_score_gemma":0.0037702338,"teacher_disagreement_score":0.007962819,"about_ca_system_score_codex":0.0011845744,"about_ca_system_score_gemma":0.0021439907,"threshold_uncertainty_score":0.02663827},"labels":[],"label_agreement":null},{"id":"W4400005506","doi":"10.1080/17474086.2024.2372325","title":"Optimizing salvage therapy for Hodgkin lymphoma: progress and future challenges","year":2024,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hodgkin lymphoma; Salvage therapy; Lymphoma; Intensive care medicine; Oncology; Medical physics; Internal medicine; Chemotherapy","score_opus":0.05508825183610309,"score_gpt":0.40248809726720497,"score_spread":0.34739984543110186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400005506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052801806,0.99925596,0.00003316628,0.00042857492,0.00007674217,0.0000023847383,0.000007659671,0.000001880274,0.00014080656],"genre_scores_gemma":[0.0006146634,0.9987179,0.000106096195,0.00032412843,0.00013566481,0.0000045282322,0.000011150998,8.3383213e-7,0.00008517291],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993787,0.00021729484,0.00013999136,0.000073758034,0.00015308808,0.00003718058],"domain_scores_gemma":[0.9983298,0.0010157317,0.000295364,0.000024999474,0.0002994559,0.000034590168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015728252,0.0006121534,0.002147515,0.001635912,0.00022464865,0.0013904718,0.0008202501,0.0014325005,0.0033936824],"category_scores_gemma":[0.002859037,0.0002280672,0.0010410274,0.0021390212,0.00043021352,0.0017647847,0.0005150938,0.0012039212,0.0008081167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009486168,0.000037358084,0.00017212404,0.12828659,0.00029196695,0.00017437652,0.00013194652,0.00036143474,0.0006614791,0.0025575112,0.02289643,0.84433395],"study_design_scores_gemma":[0.00008242755,0.00023459981,0.0021113663,0.16380388,0.0014383877,0.0022366946,0.0005703865,0.0002660294,0.00043408835,0.0055273767,0.82324815,0.00004660156],"about_ca_topic_score_codex":0.0015918093,"about_ca_topic_score_gemma":0.003309661,"teacher_disagreement_score":0.0033936824,"about_ca_system_score_codex":0.0008292407,"about_ca_system_score_gemma":0.0023122248,"threshold_uncertainty_score":0.011353016},"labels":[],"label_agreement":null},{"id":"W4401091260","doi":"10.1080/17474086.2024.2385485","title":"Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies","year":2024,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; McMaster University","funders":"","keywords":"Medicine; Immune thrombocytopenia; Autoantibody; Platelet; Immune system; Immunology; Antibody","score_opus":0.0525106016778986,"score_gpt":0.41274882760750337,"score_spread":0.36023822592960475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401091260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016572446,0.9970414,0.00015298238,0.0005411137,0.00032508944,0.000009928439,0.000027459742,0.000011175125,0.0017249751],"genre_scores_gemma":[0.0011190247,0.99664766,0.00022680746,0.0005791505,0.0003403582,0.000013234501,0.000056136694,0.0000022714817,0.0010153096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998523,0.00003175059,0.000016212376,0.000024389521,0.000060300034,0.000015074706],"domain_scores_gemma":[0.999866,0.000058506328,0.000022632263,0.0000032199293,0.00003833274,0.000011202168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002810621,0.00054048584,0.0007673319,0.0012028642,0.00016166214,0.00059676345,0.00049483974,0.0008394867,0.0060519977],"category_scores_gemma":[0.0004749686,0.00011581681,0.0005302161,0.00078011246,0.00019385369,0.0005870515,0.00039010003,0.0015216194,0.0022572728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082345774,0.000068209905,0.00008463188,0.01658354,0.00010334909,0.00017072029,0.000040479303,0.00024481202,0.001661791,0.0025975616,0.040727273,0.93763524],"study_design_scores_gemma":[0.00005072557,0.00015525578,0.0006223402,0.006314971,0.00017916945,0.0016092337,0.000037128615,0.00011291458,0.0005071793,0.0017813748,0.9886171,0.000012565282],"about_ca_topic_score_codex":0.0005821588,"about_ca_topic_score_gemma":0.0011791324,"teacher_disagreement_score":0.0060519977,"about_ca_system_score_codex":0.0003860761,"about_ca_system_score_gemma":0.0005185466,"threshold_uncertainty_score":0.02024591},"labels":[],"label_agreement":null},{"id":"W4402381249","doi":"10.1080/17474086.2024.2396617","title":"Optimizing long-term joint health in the treatment of hemophilia","year":2024,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministero della Salute; European Commission","keywords":"Medicine; Intensive care medicine; Quality of life (healthcare); Arthropathy; Hemarthrosis; Pediatrics; Surgery; Alternative medicine; Osteoarthritis; Pathology; Nursing","score_opus":0.12294797114793674,"score_gpt":0.4677403675289576,"score_spread":0.3447923963810209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402381249","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051844865,0.9996012,0.00001930665,0.00011822687,0.0000436957,0.000003428585,0.0000076277156,0.000001128729,0.00015352092],"genre_scores_gemma":[0.0010962768,0.998511,0.000076343036,0.00013033286,0.000067351284,0.0000072214775,0.0000138029845,5.763487e-7,0.00009696431],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992034,0.000248702,0.00016643282,0.00008954152,0.0002553232,0.000036665082],"domain_scores_gemma":[0.99880004,0.00072210334,0.00024811938,0.000016492184,0.00018400197,0.000029298897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012314187,0.00058792473,0.0015853196,0.0020605882,0.00024418833,0.0011239707,0.0007883647,0.0012720568,0.0040872465],"category_scores_gemma":[0.0027754162,0.00020403849,0.0010366071,0.001921877,0.00037419994,0.0008157806,0.00041745143,0.0009875599,0.0007505346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014153105,0.00005331293,0.0003087024,0.17065069,0.00059958664,0.00016180506,0.000111205176,0.00026319915,0.00061265304,0.0017440382,0.015519251,0.809834],"study_design_scores_gemma":[0.00016796078,0.00044984877,0.0056126676,0.19763197,0.0032214841,0.0036533806,0.00036444422,0.0002488429,0.00078086427,0.0028838548,0.7849234,0.00006120233],"about_ca_topic_score_codex":0.00197682,"about_ca_topic_score_gemma":0.0033513776,"teacher_disagreement_score":0.0040872465,"about_ca_system_score_codex":0.0006699095,"about_ca_system_score_gemma":0.0017895483,"threshold_uncertainty_score":0.013673186},"labels":[],"label_agreement":null},{"id":"W4404322372","doi":"10.1080/17474086.2024.2429606","title":"Global prophylaxis trends in hemophilia: a macroeconomic analysis and its association with world development indicators","year":2024,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.026750420263183423,"score_gpt":0.38633437103824275,"score_spread":0.35958395077505934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404322372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003387811,0.98641205,0.00028112697,0.0025847182,0.0002607588,0.000058820395,0.0049336404,0.000021478816,0.0020595198],"genre_scores_gemma":[0.028117953,0.96789885,0.0006876962,0.0003611627,0.00036229473,0.0000788457,0.0022087817,0.0000092697655,0.0002752245],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989755,0.00029797055,0.00022754521,0.00013059223,0.0002902631,0.00007820913],"domain_scores_gemma":[0.9971023,0.0012398448,0.00083980314,0.000047660647,0.0006745891,0.00009577312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023515152,0.0007135682,0.0013107943,0.008647047,0.00019942124,0.0015446807,0.00049471355,0.00051591266,0.0039493702],"category_scores_gemma":[0.0068651205,0.00024974465,0.0018360356,0.017672643,0.00026279697,0.0012053421,0.0007338875,0.00091850467,0.0006816143],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004436168,0.000074837924,0.05319417,0.15766865,0.004314232,0.00026743644,0.0006941482,0.0018555786,0.00031511413,0.0069355764,0.0773472,0.6968894],"study_design_scores_gemma":[0.00012749496,0.00032886857,0.26999703,0.185719,0.012815645,0.0014000186,0.0015820053,0.0020336958,0.0006776772,0.0045392714,0.520581,0.000198344],"about_ca_topic_score_codex":0.00830954,"about_ca_topic_score_gemma":0.0075968476,"teacher_disagreement_score":0.008647047,"about_ca_system_score_codex":0.0013022163,"about_ca_system_score_gemma":0.002813936,"threshold_uncertainty_score":0.016522348},"labels":[],"label_agreement":null},{"id":"W4404527095","doi":"10.1080/17474086.2024.2432358","title":"Rivaroxaban plus aspirin after lower–extremity revascularization","year":2024,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Rivaroxaban; Aspirin; Antithrombotic; Revascularization; Randomized controlled trial; Adverse effect; Intensive care medicine; Surgery; Internal medicine; Cardiology; Anesthesia; Warfarin; Myocardial infarction; Atrial fibrillation","score_opus":0.028546112154901524,"score_gpt":0.374020016958928,"score_spread":0.34547390480402645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404527095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008287392,0.99875104,0.00004979879,0.00031171064,0.00017959607,0.0000091204665,0.000023343362,0.0000035877085,0.0005888718],"genre_scores_gemma":[0.0010406614,0.9980446,0.00010933498,0.00034464334,0.00018205795,0.000011644848,0.00004007529,0.0000013504531,0.00022559376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993789,0.0001936081,0.00011308105,0.000099827375,0.00017995818,0.0000345941],"domain_scores_gemma":[0.9993309,0.00035256002,0.00018514543,0.000013557917,0.00009872756,0.00001919335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011867309,0.0006698945,0.0018684755,0.0012133932,0.00017939742,0.00096376403,0.00078089716,0.0010930639,0.0051942198],"category_scores_gemma":[0.0019625907,0.00019656275,0.0013940902,0.0011938631,0.00031159044,0.0006458311,0.00036569266,0.0013144378,0.0016753833],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002631764,0.00004266988,0.00021691987,0.12050258,0.00088545564,0.00014137205,0.00004439522,0.00026066927,0.00060153607,0.0022703714,0.036615185,0.83815557],"study_design_scores_gemma":[0.0004617541,0.00038186758,0.0031185665,0.10417938,0.0029894013,0.0028563982,0.00008086824,0.0002452664,0.0007593526,0.0031006914,0.8817887,0.00003795427],"about_ca_topic_score_codex":0.001268423,"about_ca_topic_score_gemma":0.0019401605,"teacher_disagreement_score":0.0051942198,"about_ca_system_score_codex":0.00047305756,"about_ca_system_score_gemma":0.0013758366,"threshold_uncertainty_score":0.017376363},"labels":[],"label_agreement":null},{"id":"W4406158969","doi":"10.1080/17474086.2025.2450223","title":"Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature review","year":2025,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; Cancer Care Ontario","funders":"Pfizer","keywords":"Medicine; Refractory (planetary science); Lymphoblastic Leukemia; Gemtuzumab ozogamicin; Oncology; Intensive care medicine; Leukemia; Internal medicine; Pediatrics; Stem cell","score_opus":0.020119021962433252,"score_gpt":0.34597853935283435,"score_spread":0.3258595173904011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406158969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016678551,0.9961798,0.00018792524,0.00046837685,0.00008686886,0.00042132413,0.0007188044,0.000009994946,0.00025902808],"genre_scores_gemma":[0.019869806,0.9768588,0.00095598993,0.0008058185,0.000092809176,0.0007934525,0.00050505233,0.000008031155,0.000110181354],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9933891,0.0020433015,0.0029333076,0.000530726,0.00092460477,0.00017887498],"domain_scores_gemma":[0.9733589,0.017786194,0.006338307,0.00032191543,0.0018702287,0.00032442602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073372046,0.0014446457,0.009548421,0.01266545,0.00060172926,0.0029617387,0.0020416686,0.0018363791,0.004453715],"category_scores_gemma":[0.03240679,0.0009083758,0.0074968776,0.011693918,0.00094980834,0.0026816488,0.001488512,0.0009818156,0.0003348824],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019228015,0.00001000451,0.0007302274,0.96903044,0.0063852672,0.000068986235,0.00013661972,0.00006786737,0.00010568678,0.00014706036,0.0010428115,0.022082677],"study_design_scores_gemma":[0.00027165812,0.0001543033,0.0031330073,0.9076191,0.07597446,0.00032778052,0.00031135036,0.00008662782,0.00014354955,0.00037594652,0.011560047,0.000042246622],"about_ca_topic_score_codex":0.0061999345,"about_ca_topic_score_gemma":0.015820952,"teacher_disagreement_score":0.01266545,"about_ca_system_score_codex":0.0034208389,"about_ca_system_score_gemma":0.010521087,"threshold_uncertainty_score":0.03880328},"labels":[],"label_agreement":null},{"id":"W4409922637","doi":"10.1080/17474086.2025.2500607","title":"Revolutionizing hypertension treatment: aprocitentan’s dual action against resistant hypertension","year":2025,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Medicine; Resistant hypertension; Internal medicine; Cardiology; Intensive care medicine; Blood pressure","score_opus":0.04366818383536949,"score_gpt":0.3392756055108664,"score_spread":0.2956074216754969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409922637","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009631939,0.14711912,0.0002533519,0.041478254,0.80713004,0.00006354065,0.00017856226,0.00014143405,0.003539468],"genre_scores_gemma":[0.0011251535,0.117393255,0.00035389524,0.054303814,0.8134478,0.000054018416,0.00013654876,0.000067153254,0.013118329],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99763083,0.0005454387,0.00029376967,0.00021389591,0.001132335,0.00018381252],"domain_scores_gemma":[0.99487126,0.0019618357,0.00037313165,0.000089249435,0.00198197,0.00072258443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050431765,0.001975429,0.0026589911,0.0016286527,0.0012859796,0.0036018125,0.0029729472,0.0066261436,0.012595975],"category_scores_gemma":[0.010343966,0.0004967189,0.002079949,0.00086326763,0.0010956012,0.0036206495,0.0009952717,0.012374969,0.009580954],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114197785,0.0000188212,0.000021514625,0.0012853502,0.000059103215,0.00004281772,0.00001709299,0.000023723755,0.000093217604,0.00060281594,0.9642997,0.033421684],"study_design_scores_gemma":[0.00021790905,0.00010496242,0.0002042357,0.0016685972,0.00019331172,0.00017096946,0.000036252186,0.00008194697,0.00011836871,0.0011779345,0.9960064,0.000019194375],"about_ca_topic_score_codex":0.0012188735,"about_ca_topic_score_gemma":0.004720022,"teacher_disagreement_score":0.012595975,"about_ca_system_score_codex":0.0015242477,"about_ca_system_score_gemma":0.0028935254,"threshold_uncertainty_score":0.042137742},"labels":[],"label_agreement":null},{"id":"W4412366402","doi":"10.1080/17474086.2025.2534704","title":"Factor first! Emergency department management of persons with hemophilia: a single-center study","year":2025,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; University of Calgary","funders":"","keywords":"Medicine; Emergency department; Guideline; Psychological intervention; Emergency medicine; Bleed; Quality management; Single Center; Pediatrics; Medical emergency; Internal medicine; Surgery; Management system","score_opus":0.03716599418714921,"score_gpt":0.36626585261466027,"score_spread":0.32909985842751105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412366402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977762,0.0008504365,0.00005145602,0.00015274236,0.000011140378,0.000032585143,0.00052316877,0.000003169562,0.0005990503],"genre_scores_gemma":[0.9986696,0.00044992508,0.000082992374,0.00011697874,0.000018531755,0.000018219689,0.00039651676,0.0000014715498,0.00024568895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994165,0.00009806757,0.00004794712,0.00010921266,0.00017253976,0.00015585648],"domain_scores_gemma":[0.99848014,0.00017196566,0.0006678722,0.00006854492,0.00023323648,0.0003781708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007381436,0.00028228856,0.00035968213,0.0006322857,0.0007016249,0.00095244485,0.0006991699,0.000575209,0.0019694348],"category_scores_gemma":[0.0018767079,0.00031976038,0.00054206175,0.00163404,0.00031025385,0.00045742578,0.000543414,0.00070234376,0.00024771018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054611726,0.000059780916,0.99824107,0.00002249239,0.000046020676,0.00005447108,0.00012123573,0.000012528837,0.000024837163,0.000009844225,0.00021395429,0.0011391363],"study_design_scores_gemma":[0.000014371893,0.00009342969,0.9988134,0.000039301907,0.00004399804,0.00012174831,0.00056091807,0.00006488811,0.000009559493,0.0000080693535,0.00022728146,0.0000029710418],"about_ca_topic_score_codex":0.22834267,"about_ca_topic_score_gemma":0.31852418,"teacher_disagreement_score":0.22834267,"about_ca_system_score_codex":0.0022112844,"about_ca_system_score_gemma":0.0028936078,"threshold_uncertainty_score":0.45402712},"labels":[],"label_agreement":null},{"id":"W4412611776","doi":"10.1080/17474086.2025.2535422","title":"Mesenchymal stromal cells for the prophylaxis of graft-versus-host disease after hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials","year":2025,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Mesenchymal stem cell; Graft-versus-host disease; Hematopoietic stem cell transplantation; Transplantation; Meta-analysis; Stem cell; Randomized controlled trial; Haematopoiesis; Disease; Immunology; Surgery; Internal medicine; Pathology; Biology","score_opus":0.10830186099737911,"score_gpt":0.4299351816037333,"score_spread":0.3216333206063542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412611776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012686521,0.98478806,0.00091531215,0.00027215356,0.00021711075,0.00028635914,0.00047536832,0.000038919094,0.000320219],"genre_scores_gemma":[0.4196245,0.5716426,0.0041994196,0.0012927057,0.00047749467,0.0011918694,0.001113625,0.00006282253,0.00039499343],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.986159,0.008477778,0.002839466,0.0012549488,0.00087411003,0.00039477178],"domain_scores_gemma":[0.97546345,0.018716896,0.00385962,0.0007183792,0.0009510129,0.00029069482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016899578,0.002897154,0.017716879,0.003969669,0.00050969695,0.00332212,0.001979424,0.0022503394,0.0038321798],"category_scores_gemma":[0.031418834,0.0012053893,0.04909173,0.0045869066,0.00075953885,0.0015722945,0.0010793344,0.0024509018,0.00028228696],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008854131,0.000040764204,0.0036349706,0.13479742,0.8437033,0.00009231769,0.000036239147,0.0009165564,0.0002567219,0.00011961766,0.00035661345,0.007191273],"study_design_scores_gemma":[0.0016885767,0.0003656954,0.0022375062,0.0070360415,0.98745733,0.00004931914,0.000018295532,0.00026522853,0.00009335175,0.00015633924,0.00061865314,0.000013687713],"about_ca_topic_score_codex":0.0036846097,"about_ca_topic_score_gemma":0.0054686186,"teacher_disagreement_score":0.017716879,"about_ca_system_score_codex":0.0019889486,"about_ca_system_score_gemma":0.0018010074,"threshold_uncertainty_score":0.08937454},"labels":[],"label_agreement":null},{"id":"W4412695930","doi":"10.1080/17474086.2025.2540401","title":"Does Down syndrome affect the prognosis of acute lymphoblastic leukemia? A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoblastic Leukemia; Affect (linguistics); Meta-analysis; Intensive care medicine; Oncology; Leukemia; Internal medicine","score_opus":0.03156545313694228,"score_gpt":0.3752676643229227,"score_spread":0.34370221118598043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412695930","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042605666,0.99429613,0.0003391527,0.00021381558,0.00011172892,0.00020745627,0.00042330602,0.000014008901,0.00013390627],"genre_scores_gemma":[0.16047262,0.8344168,0.0017292871,0.0008138427,0.0003081582,0.0011509531,0.00079062296,0.000023255834,0.00029441522],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99088657,0.0044230735,0.0024325456,0.0009879692,0.00094981276,0.00032004755],"domain_scores_gemma":[0.9760645,0.01838186,0.0033520872,0.0005634532,0.0013176202,0.00032045756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012535732,0.0024205474,0.018856287,0.007772192,0.0006462042,0.0032987625,0.0020325524,0.0022921502,0.003909624],"category_scores_gemma":[0.03150647,0.0012357297,0.03258017,0.008211701,0.0008345219,0.0018000621,0.0014608519,0.0016803328,0.00024270352],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015860115,0.000028083114,0.006188585,0.4257149,0.55363137,0.00014415839,0.000087394044,0.00052867073,0.00015076708,0.00013772583,0.0005804754,0.01122179],"study_design_scores_gemma":[0.0004128356,0.00018017985,0.004613427,0.02812725,0.96461284,0.00010448566,0.00004227936,0.00019317133,0.00006561164,0.00018752312,0.0014386408,0.000021713795],"about_ca_topic_score_codex":0.0072679636,"about_ca_topic_score_gemma":0.01312213,"teacher_disagreement_score":0.018856287,"about_ca_system_score_codex":0.0028252634,"about_ca_system_score_gemma":0.003509857,"threshold_uncertainty_score":0.0662961},"labels":[],"label_agreement":null},{"id":"W4412826219","doi":"10.1080/17474086.2025.2542867","title":"Cognitive impairment in hematology patients planned for chimeric antigen receptor T-cell therapy","year":2025,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chimeric antigen receptor; Hematology; Oncology; Internal medicine; Immunology; Immunotherapy; Cancer","score_opus":0.016132768515435242,"score_gpt":0.3490958760747081,"score_spread":0.33296310755927283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412826219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991359,0.00017601911,0.000019767149,0.000053462543,0.0000058464634,0.000015918866,0.00006297871,0.0000022547003,0.0005279307],"genre_scores_gemma":[0.99972314,0.00007044274,0.000023637998,0.000044062523,0.000008944173,0.0000063599214,0.00007154809,3.660828e-7,0.0000515121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997807,0.000045807345,0.000020740097,0.000029282388,0.000049186874,0.00007428626],"domain_scores_gemma":[0.99945575,0.0000863857,0.00020494417,0.000013569804,0.000038072485,0.00020119919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003164719,0.00025888562,0.00033677442,0.0005722724,0.0005991523,0.00054864574,0.00020162013,0.0002746468,0.0010291733],"category_scores_gemma":[0.0017234473,0.00012605498,0.00026580621,0.0006468118,0.00028270224,0.00023542141,0.0003177868,0.00057909515,0.0001359361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024340206,0.00012500642,0.9959144,0.000010868802,0.000011880157,0.0006742106,0.00011305394,0.000042779153,0.000111110625,0.000012742328,0.00015302909,0.0025875678],"study_design_scores_gemma":[0.000030837025,0.00076921633,0.9961951,0.000011000418,0.000026444359,0.0021035355,0.0002812646,0.00020765058,0.000092285445,0.000047659214,0.00023001511,0.000005104135],"about_ca_topic_score_codex":0.0046324786,"about_ca_topic_score_gemma":0.0048603434,"teacher_disagreement_score":0.0046324786,"about_ca_system_score_codex":0.0005646871,"about_ca_system_score_gemma":0.0005211279,"threshold_uncertainty_score":0.009211004},"labels":[],"label_agreement":null},{"id":"W4413772971","doi":"10.1080/17474086.2025.2554652","title":"Clinical decisions and factors influencing the management of persons with hemophilia requiring antithrombotic therapy: a qualitative study","year":2025,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of Calgary","funders":"Canadian Hemophilia Society","keywords":"Medicine; Antithrombotic; Intensive care medicine; Internal medicine","score_opus":0.10838896773887388,"score_gpt":0.4944768954409317,"score_spread":0.3860879277020578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413772971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852394,0.0010611819,0.003275254,0.0051124897,0.00006799644,0.00045208007,0.000249498,0.000017273182,0.0045247045],"genre_scores_gemma":[0.9915298,0.001353276,0.002245164,0.0018402427,0.000020108982,0.0004007525,0.00008899176,0.000016241045,0.0025053113],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.98857015,0.0087191295,0.00027052677,0.00049498334,0.0006437246,0.0013014419],"domain_scores_gemma":[0.969106,0.024764268,0.001402745,0.0004447409,0.00216644,0.0021158187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01644877,0.0004317799,0.00060794206,0.0012348114,0.008954438,0.0028954851,0.0015241825,0.0016581236,0.0033525866],"category_scores_gemma":[0.022136776,0.0005118318,0.00037386938,0.0013149794,0.007706455,0.0027609356,0.0031987606,0.0024012318,0.00027298465],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026486072,0.00005004716,0.0023162859,0.00015231712,0.0000036330116,0.00039049992,0.9908311,0.000035354577,0.0002964573,0.00095289503,0.00063242775,0.004312546],"study_design_scores_gemma":[0.0000055680784,0.000035391255,0.00093150174,0.00019535208,0.000003292515,0.00011523312,0.992334,0.00007488,0.00013420642,0.00025104167,0.00590979,0.000009876542],"about_ca_topic_score_codex":0.047240257,"about_ca_topic_score_gemma":0.06623475,"teacher_disagreement_score":0.047240257,"about_ca_system_score_codex":0.010391452,"about_ca_system_score_gemma":0.014247672,"threshold_uncertainty_score":0.0939306},"labels":[],"label_agreement":null},{"id":"W4415842547","doi":"10.1080/17474086.2025.2574715","title":"Quantifying the optimal factor VIII levels to achieve patient-centric and clinician-relevant outcomes among people with hemophilia A: a SHELF elicitation study","year":2025,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"Swedish Orphan Biovitrum","keywords":"Off the shelf; Clinical trial; MEDLINE; Risk factor; Risk assessment","score_opus":0.04957277852374742,"score_gpt":0.3999604426526519,"score_spread":0.3503876641289045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415842547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936819,0.00021896792,0.0042881286,0.00019210023,0.0000064513715,0.00041675262,0.00019481857,0.0000067291257,0.000994187],"genre_scores_gemma":[0.9918989,0.0001615421,0.006735709,0.00013396566,0.000009889596,0.00072018616,0.00019126278,0.0000032808146,0.00014515965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98482853,0.012489836,0.0009678864,0.000604268,0.00079766195,0.00031185278],"domain_scores_gemma":[0.8784066,0.105041265,0.0073413206,0.0025366873,0.0057254336,0.00094867713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03148623,0.00041617858,0.00045040983,0.00076774805,0.0005910641,0.0012791996,0.0005631837,0.0010178374,0.0022074622],"category_scores_gemma":[0.060547303,0.000239712,0.000830257,0.0005658754,0.0008225306,0.0011245518,0.0017478291,0.0007342065,0.00024455134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008042198,0.008024374,0.4628793,0.0058563747,0.001317031,0.000738412,0.1725646,0.011166928,0.006106033,0.005252239,0.0045251427,0.31352732],"study_design_scores_gemma":[0.002744785,0.042643063,0.664234,0.0041874633,0.0025096305,0.0018042735,0.14309882,0.084119394,0.012678568,0.019124378,0.022370905,0.00048473725],"about_ca_topic_score_codex":0.0007373312,"about_ca_topic_score_gemma":0.0011926033,"teacher_disagreement_score":0.03148623,"about_ca_system_score_codex":0.0012359658,"about_ca_system_score_gemma":0.001187484,"threshold_uncertainty_score":0.16651708},"labels":[],"label_agreement":null},{"id":"W7117141018","doi":"10.1080/17474086.2025.2610282","title":"Improving transfusion access through improved policy: a call for a less fragmented blood supply","year":2025,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"","keywords":"Reimbursement; Interoperability; Psychological intervention; Data sharing; Corporate governance; Blood supply","score_opus":0.02563344983874305,"score_gpt":0.33576347762796205,"score_spread":0.310130027789219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117141018","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014496263,0.103138596,0.004236722,0.88033414,0.0037894268,0.000105456274,0.00016392765,0.00011167034,0.0066705076],"genre_scores_gemma":[0.09311788,0.2873148,0.040797893,0.55991447,0.01319229,0.0009954541,0.00052418484,0.00016026471,0.003982779],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9637617,0.023739628,0.0027974213,0.0019823639,0.0056728255,0.0020460312],"domain_scores_gemma":[0.79525316,0.14400834,0.018864775,0.007723342,0.026377954,0.007772431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06534111,0.00072974287,0.001968625,0.0038358308,0.0018757222,0.013692885,0.004241025,0.011949703,0.018602736],"category_scores_gemma":[0.16816811,0.00064715516,0.0024100603,0.0047029452,0.007954466,0.022295507,0.006501719,0.014903164,0.0022348205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025147575,0.00033579042,0.003070906,0.024667641,0.0005559393,0.00026606538,0.002702254,0.0028619226,0.00051415834,0.3297403,0.27881002,0.35622355],"study_design_scores_gemma":[0.00025455636,0.00020613165,0.00589673,0.08193699,0.0003618862,0.00030238886,0.0039112642,0.0010188121,0.00049717206,0.13701665,0.7684918,0.00010561351],"about_ca_topic_score_codex":0.0139498785,"about_ca_topic_score_gemma":0.0115334,"teacher_disagreement_score":0.06534111,"about_ca_system_score_codex":0.015323843,"about_ca_system_score_gemma":0.057234082,"threshold_uncertainty_score":0.3455609},"labels":[],"label_agreement":null}]}